FDA and DEA documents from the Federal Register on mental health and controlled substances, and clinical-trial registrations from ClinicalTrials.gov. Documents are dated by publication and registrations by the day ClinicalTrials.gov first posted them.
A Johns Hopkins team coded 600 public comments from the five most-commented FDA reviews of 2020 to 2024 and found 90.2 percent supported approval. Its own appendix of 44 advisory committee reviews shows comment volume tracking committee votes in no consistent way. In the five cases, FDA's documents point to other grounds, among them inspections, manufacturing comparability, durability data, post hoc analyses and one Center Director override of his own reviewers.
CMS's final 2027 rule raises psychiatric collaborative care's work value above its July proposal, and a modeled twelve-month episode gains about 28 percent. But the treating practitioner reports the claim, and psychiatry's own specialty estimate is about 2 percent, before a 2.31 percent cut to the non-qualifying conversion factor.
A nitazene opioid, a methoxy tryptamine and a cocaine-like tropane were designated the same day by two different systems: nationally under the Pharmaceuticals and Medical Devices Act, in force November 6, and by at least five prefectures under their own ordinances, in force October 28. The prefectural layer is a bridge. Aichi has designated 250 substances since 2012, every one has lapsed into the national list, and its current roster is these three.
A preprint from the University of Mississippi's natural products center bought 46 chewable products labeled as cat's claw and found undeclared kratom alkaloids in every one. Thirty-nine contained one or both of two compounds the DEA placed in Schedule I in August; the third scheduled compound was not in the laboratory's analyte panel. Eight products that promised no kratom and no 7-OH contained both. FDA's own public page on these compounds, current to October 12, does not mention cat's claw.
DEA is replacing the 7-hydroxymitragynine threshold it proposed in July with a two-part test: more than 1 mg per gram, or less than 100 parts mitragynine to one part of the potent alkaloids. The proposal is not a final order, and none had issued as of October 27. On the arithmetic, the new test can be looser or tighter than the old one, depending on a product's alkaloid mix. DEA says it has made no finding that anything below the line is safe.
Starting in 2027, VA plans to require a signed consent form before prescribing an antidepressant to a veteran younger than 30. Ten months earlier it told the Senate a broader signature mandate could delay care. It has not explained the age line, and the FDA's own trial analysis did not find added suicidality risk at ages 25 to 34.
The White House added nine more drugmakers to its most-favored-nation pricing program, bringing the total to 26 companies covering an estimated 89 percent of the branded drug market. None of the new nine build their business around psychiatric drugs. That's beside the point: the company that makes esketamine signed on months ago, and the whole arrangement is voluntary, unenforced by law, and largely undisclosed to Congress.
Executive Order 2026-037 creates a scientific advisory committee to study whether Puerto Rico should build a pilot clinical research program for emerging therapies, including psilocybin, MDMA, and ibogaine, with veterans named as a priority population. The order states that it does not authorize offering these therapies as part of routine clinical practice, and any future research would still need separate regulatory authorization, a distinction worth stating plainly before the headline runs ahead of it.
CMS finalized its FY 2027 payment rule for inpatient psychiatric facilities with an in-line-with-inflation rate increase. Buried in the same rule is a new cap on outlier payments, aimed specifically at high-cost facilities, that takes effect a year later and could matter more to some operators than the headline rate does.
CMS's CY 2027 physician fee schedule cuts both Medicare conversion factors, a system-wide reimbursement headwind. But the same rule extends Medicare's telehealth mental health flexibility through 2027, and last year's most contested pay cut specifically exempted the time-based codes psychiatry and psychotherapy mostly bill under. The rule is a mixed signal, not a uniform one, and the mix matters more than the headline number.
A federal Schedule I proposal would close the retail loophole that has let tianeptine, an atypical antidepressant abroad and an opioid-like supplement in unregulated US retail, spread through the same gas-station-and-smoke-shop channel as kratom's concentrated derivatives. It is the third distinct DEA scheduling action against this retail category in two weeks.
Five FDA acceleration programs get conflated in coverage. They do different things, require different evidence, and create different post-approval obligations. A reference for telling them apart.
Six days after Trump's executive order, the agency named three programs for one-to-two-month reviews. The picks reset the field's near-term hierarchy. FDA has not said why it chose them or whether Resilient, whose MDMA program it rejected in 2024, applied.
Regulatory documents: Federal Register publications from Nov 10, 2024 to Nov 17, 2026.
Clinical-trial registrations: first posted from Aug 12, 2026 to Nov 17, 2026.
Showing 410 regulatory documents and 553 clinical-trial registrations for all available history.
Regulatory documents
410
FDA and DEA documents published in the Federal Register. The date shown is the publication date.
No FDA documents meet this tracker’s selection criteria for the selected period. The Federal Register was last checked successfully on Nov 17, 2026.
No DEA documents meet this tracker’s selection criteria for the selected period. The Federal Register was last checked successfully on Nov 17, 2026.
Published November 12, 2026
DEA
Schedules of Controlled Substances: Placement of Oveporexton in Schedule IV
Interim final rule · Effective Nov 12, 2026 · Comments due Dec 14, 2026
scheduling
On August 5, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Orzeyful (oveporexton) for the treatment of narcolepsy type 1 in adults. The Department of Health and Human Services (HHS) provided the Drug Enforcement Administration…
Importer of Controlled Substances Application: NSI Lab Solutions LLC
Notice · Comments due Dec 14, 2026
scheduling
NSI Lab Solutions LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2027
Notice
scheduling
The Drug Enforcement Administration (DEA) proposes to establish the 2027 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine…
Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sale) Pursuant to 21 U.S.C. 826(h)
Final order · Effective Nov 10, 2026
scheduling
The Drug Enforcement Administration (DEA) is adjusting the 2026 aggregate production quota for the schedule II controlled substances d,l-amphetamine, d-amphetamine (for sale), hydromorphone, and methylphenidate (for sale). In making this determination, DEA has considered the…
Specific Listing for 3-Chloromethcathinone, A Currently Controlled Schedule I Substance
Final rule · Effective Nov 6, 2026
scheduling
The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3- chloromethcathinone; 3-CMC) in schedule I of the Controlled Substances Act (CSA). Although…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Navinta LLC
Notice · Comments due Jan 4, 2027
scheduling
Navinta LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Diamond Animal Health, Inc.
Notice · Comments due Dec 7, 2026
scheduling
Diamond Animal Health, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Noramco
Notice · Comments due Dec 7, 2026
scheduling
Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences
Notice · Comments due Jan 4, 2027
scheduling
AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Globyz Pharma LLC
Notice · Comments due Dec 2, 2026
scheduling
Globyz Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Conforming Amendment Regarding the Criminal Law Technical Amendments Act of 2002
Final rule · Effective Nov 2, 2026
scheduling
The Criminal Law Technical Amendments Act of 2002 ("Technical Amendments Act") became law on November 2, 2002, as part of the 21st Century Department of Justice Appropriations Authorization Act. The Technical Amendments Act amended sections 401(d), 402(c), and 403 of the…
Schedules of Controlled Substances: Placement of Centanafadine in Schedule III
Interim final rule · Effective Oct 30, 2026 · Comments due Nov 30, 2026
scheduling
On July 24, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder in adults and pediatric patients aged 6 years and older, weighing at least 20 kg. …
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
Notice · Comments due Dec 28, 2026
scheduling
Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Notice · Comments due Nov 18, 2026
scheduling
Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.
Notice · Comments due Dec 18, 2026
scheduling
Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Groff Health Inc
Notice · Comments due Dec 18, 2026
scheduling
Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Nov 18, 2026
scheduling
Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Dec 18, 2026
scheduling
Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research University of Mississippi/NCNPR
Notice · Comments due Dec 18, 2026
scheduling
National Center for Natural Products Research University of Mississippi/NCNPR has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Nov 18, 2026
scheduling
National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Groff Health Inc.
Notice · Comments due Nov 18, 2026
scheduling
Groff Health Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: DMS Pharmaceutical Group
Notice · Comments due Nov 18, 2026
scheduling
DMS Pharmaceutical Group has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Halo Pharmaceutical Inc.
Notice · Comments due Nov 18, 2026
scheduling
Halo Pharmaceutical Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I
Notice of intent
scheduling
The Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine and mitragynine pseudoindoxyl (including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers…
Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I
Notice of intent
scheduling
The Drug Enforcement Administration (DEA) is issuing this notice of intent to publish a temporary order to schedule two 7- hydroxymitragynine-related substances (MGM-15 and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers…
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
Final determination · Effective Nov 9, 2026
scheduling
The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available…
Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
Correction · Correction effective Oct 9, 2026
scheduling
On August 12, 2026, the Drug Enforcement Administration (DEA) published a temporary order placing O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its salts, isomers, and salts of isomers…
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information
Notice · Comments due Nov 20, 2026
psychedelics
The Food and Drug Administration (FDA or the Agency) is describing the approaches it is considering for the design of early- phase clinical trials of ibogaine drug products and is opening a public docket to receive comments. The Department of Health and Human Services (HHS) is…
This proposed rule would amend the regulations of the Drug Enforcement Administration (DEA) to extend the time allowed for reexports of controlled substances outside of the European Economic Area from 180 days from the date of original release from U.S. Customs and Border…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Nov 27, 2026
scheduling
Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated
Notice · Comments due Nov 27, 2026
scheduling
Cargill, Incorporated has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Oct 28, 2026
scheduling
Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
Notice · Comments due Nov 23, 2026
scheduling
Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
Notice · Comments due Nov 23, 2026
scheduling
Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (I)
Notice · Comments due Oct 26, 2026
scheduling
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Notice · Comments due Oct 26, 2026
scheduling
Cambridge Isotope Laboratories, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Notice · Comments due Dec 23, 2026
scheduling
Cambridge Isotope Laboratories, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I
Proposed rule · Comments due Oct 23, 2026
scheduling
The Drug Enforcement Administration proposes placing five tryptamine hallucinogens, 4-hydroxy-N,N-diisopropyltryptamine (other names: 4-OH-DiPT; 3-(2-(diisopropylamino)ethyl)-1H-indol-4- ol), 5-methoxy-alpha-methyltryptamine (other names: 5-MeO-AMT; 1-(5…
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
Final rule · Effective Oct 21, 2026
scheduling
With the issuance of this final rule, the Drug Enforcement Administration places the substance diphenidine (1-(1,2- diphenylethyl)piperidine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Oct 14, 2026
scheduling
Irvine Labs, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.
Notice · Comments due Nov 13, 2026
scheduling
Cambrex High Point, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Nov 9, 2026
scheduling
Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due Oct 8, 2026
scheduling
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Cambrex High Point, Inc.
Notice · Comments due Oct 8, 2026
scheduling
Cambrex High Point, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Notice · Comments due Oct 8, 2026
scheduling
Fresenius Kabi USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
AndersonBrecon, Inc DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
Interim final rule · Effective Aug 27, 2026 · Comments due Sep 28, 2026
scheduling
On May 29, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Cypsedo (cipepofol) for induction of general anesthesia in adults undergoing surgery. The Department of Health and Human Services provided the Drug Enforcement…
Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Aug 27, 2026
scheduling
The Drug Enforcement Administration (DEA) issues this temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4- yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4…
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
Temporary scheduling order · Effective Aug 26, 2026
scheduling
The Drug Enforcement Administration (DEA) is issuing this temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Curia New York Inc.
Notice · Comments due Sep 25, 2026
scheduling
Curia New York Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Oct 26, 2026
scheduling
Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Notice · Comments due Oct 26, 2026
scheduling
Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Experic LLC
Notice · Comments due Sep 25, 2026
scheduling
Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Sep 25, 2026
scheduling
Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments
Notice · Comments due Sep 3, 2026
scheduling
The Food and Drug Administration (FDA or Agency) is providing interested persons with the opportunity to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of eight drug…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Notice · Comments due Oct 26, 2026
scheduling
Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals
Notice · Comments due Oct 26, 2026
scheduling
Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Chattem Chemicals
Notice · Comments due Sep 24, 2026
scheduling
Chattem Chemicals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Prof Compounding CTS of Ameri
Notice · Comments due Sep 24, 2026
scheduling
Prof Compounding CTS of Ameri has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc.
Notice · Comments due Sep 24, 2026
scheduling
Galephar Pharmaceutical Research Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute SRI Montana Satellite Laboratory
Notice · Comments due Oct 26, 2026
scheduling
Scottsdale Research Institute SRI Montana Satellite Laboratory has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Curia Missouri Inc.
Notice · Comments due Oct 26, 2026
scheduling
Curia Missouri Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Vici Health Sciences, LLC
Notice · Comments due Sep 24, 2026
scheduling
Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Biopharmaceutical Research Company
Notice · Comments due Sep 24, 2026
scheduling
Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Curia New York Inc
Notice · Comments due Oct 26, 2026
scheduling
Curia New York Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company
Notice · Comments due Oct 26, 2026
scheduling
Biopharmaceutical Research Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Exempt Chemical Preparations Under the Controlled Substances Act
Notice · Comments due Oct 13, 2026
scheduling
The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2026, and June 30, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through…
Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
Temporary scheduling order · Effective Aug 12, 2026
scheduling
The Drug Enforcement Administration issues this temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and…
Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
Proposed rule · Comments due Sep 10, 2026
scheduling
The Drug Enforcement Administration proposes to transfer suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)…
Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical
Proposed rule · Comments due Sep 2, 2026
scheduling
The Drug Enforcement Administration is proposing to modify the listing of the list I chemical 3,4-MDP-2-P methyl glycidic acid (also known as PMK glycidic acid) to include esters of 3,4-MDP-2-P methyl glycidic acid, not listed elsewhere in the Controlled Substances Act (CSA)…
Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem
Notice · Comments due Sep 21, 2026
scheduling
American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
Notice · Comments due Sep 21, 2026
scheduling
Cerilliant Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to supplementary information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Catalent Greenville, Inc.
Notice · Comments due Aug 17, 2026
scheduling
Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Unither Manufacturing LLC
Notice · Comments due Aug 17, 2026
scheduling
Unither Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals LLC
Notice · Comments due Sep 14, 2026
scheduling
AMPAC Fine Chemicals LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Catalent CTS, LLC
Notice · Comments due Aug 17, 2026
scheduling
Catalent CTS, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability
Notice
psychedelics
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry titled "Psychedelic Drugs: Considerations for Clinical Investigations." Because interest in the therapeutic potential of psychedelic drugs has been increasing and…
Considerations for Potential Future Therapeutic Use of Psychedelic Drugs; Public Hearing; Request for Comments
Notice
psychedelics
The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing on the potential future therapeutic use of psychedelic drugs. In collaboration with federal partners, FDA is holding this public hearing to obtain feedback and perspectives on issues…
Designation of Phenethyl Halides as List I Chemicals
Proposed rule · Comments due Aug 10, 2026
scheduling
The Drug Enforcement Administration is proposing the control of phenethyl halides as list I chemicals under the Controlled Substances Act (CSA). Phenethyl halides are important to the illicit manufacture of fentanyl, as well as fentanyl analogues, and fentanyl- related…
Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
Proposed rule · Comments due Aug 7, 2026
scheduling
The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever…
Importer of Controlled Substances Application: Benuvia Operations, LLC.
Notice · Comments due Aug 6, 2026
scheduling
Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
Notice of intent
scheduling
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and…
Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
Notice of intent
scheduling
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine above a specified threshold, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever…
Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
Notice of intent
scheduling
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro- 2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: United States Pharmacopeial Convention
Notice · Comments due Jul 30, 2026
scheduling
United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc.
Notice · Comments due Jul 30, 2026
scheduling
Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Aug 31, 2026
scheduling
Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)
Notice · Comments due Jul 30, 2026
scheduling
Almac Clinical Services Incorp. (ACSI) has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Notice · Comments due Jul 30, 2026
scheduling
Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation
Final order · Effective Jun 30, 2026
The Food and Drug Administration (FDA) is classifying the monitor for opioid induced impairment of oxygenation into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for…
Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
Notice of intent
scheduling
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol), including its isomers…
Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
Correction · Correction effective Jun 24, 2026
scheduling
On March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
Notice · Comments due Jul 17, 2026
scheduling
Wedgewood Pharmacy LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Jul 17, 2026
scheduling
AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Aphena Pharma Solutions MD, LLC
Notice · Comments due Jul 17, 2026
scheduling
Aphena Pharma Solutions MD, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Jul 17, 2026
scheduling
Veranova, L.P. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Jul 17, 2026
scheduling
Scottsdale Research Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Jul 17, 2026
scheduling
AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Arizona Department of Corrections
Notice · Comments due Jul 17, 2026
scheduling
Arizona Department of Corrections has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Notice · Comments due Jul 15, 2026
scheduling
VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Aug 14, 2026
scheduling
Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Cerilliant Corporation
Notice · Comments due Jul 15, 2026
scheduling
Cerilliant Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Final rule · Effective Jul 9, 2026
scheduling
The "Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (the SUPPORT Act)," which became law on October 24, 2018, amended the Controlled Substances Act to expand the conditions a practitioner must meet to…
Importer of Controlled Substances Application: CalCog Inc.
Notice · Comments due Jul 8, 2026
scheduling
CalCog Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
Proposed rule · Comments due Jun 25, 2026
scheduling
The Drug Enforcement Administration proposes placing diphenidine (1-(1,2-diphenylethyl)piperidine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act.
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
Proposed rule · Comments due Jun 25, 2026
scheduling
The Drug Enforcement Administration (DEA) proposes to revoke the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products list but whose National Drug Code (NDC) is inactive because they are no longer…
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Temporary scheduling order · Effective May 22, 2026
pharma · scheduling
The Drug Enforcement Administration (DEA) issues this temporary order to schedule 2-(2-fluorophenyl)-2- (methylamino)cyclohexan-1-one (commonly known as 2- fluorodeschloroketamine or 2-FDCK), including its salts, isomers, and salts of isomers whenever the existence of such…
Revision of Applications for Manufacturing and Procurement Quotas
Proposed rule · Comments due Jul 20, 2026
scheduling
The Drug Enforcement Administration (DEA) proposes to revise existing regulations relating to the management of quotas for schedule I and II controlled substances and the list I chemicals, ephedrine, pseudoephedrine, and phenylpropanolamine, to be utilized by DEA- registered…
Exempt Chemical Preparations Under the Controlled Substances Act
Notice · Comments due Jul 20, 2026
scheduling
The applications for exempt chemical preparations received by the Drug Enforcement Administration between July 1, 2025, and March 31, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Amneal Pharmaceuticals, LLC
Notice · Comments due Jun 22, 2026
scheduling
Amneal Pharmaceuticals, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Organix Chemistry Solutions LLC
Notice · Comments due Jul 20, 2026
scheduling
Organix Chemistry Solutions, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Jul 17, 2026
scheduling
Benuvia Operations, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Final rule · Effective May 13, 2026
scheduling
With the issuance of this final rule, the Drug Enforcement Administration places 5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3- b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers…
Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
Final rule · Effective May 4, 2026
scheduling
The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H- benzo[c]chromen-1-ol (also known as hexahydrocannabinol, and HHC) in schedule I of the…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Notice · Comments due Jul 6, 2026
scheduling
Patheon API Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
Notice · Comments due Jun 3, 2026
scheduling
ANI Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc.
Notice · Comments due Jul 6, 2026
scheduling
ANI Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc.
Notice · Comments due Jul 6, 2026
scheduling
Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
Final rule · Effective May 1, 2026
scheduling
With the issuance of this final rule, the Drug Enforcement Administration places methyl 2-[[1-(4-fluorobutyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA), N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1…
Schedules of Controlled Substances: Rescheduling of Marijuana; Withdrawal
Proposed rule
cannabis · scheduling
The Department of Justice published a notice of proposed rulemaking in the Federal Register on May 21, 2024, which proposed to transfer marijuana from schedule I of the Controlled Substances Act to schedule III. The Drug Enforcement Administration ("DEA") published a notice of…
Schedules of Controlled Substances: Rescheduling of Marijuana
Proposed rule
cannabis · scheduling
This is notice that the Drug Enforcement Administration ("DEA") will hold a hearing with respect to the proposed rescheduling of marijuana into schedule III of the Controlled Substances Act beginning June 29, 2026. The proposed rescheduling of marijuana was initially proposed…
Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements
Final rule · Effective Apr 28, 2026
cannabis · scheduling
With the issuance of this final rule, which constitutes a final order, the Acting Attorney General of the U.S. Department of Justice places drug products containing marijuana that have been approved by the Food and Drug Administration (FDA) in schedule III of the Controlled…
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
Final rule · Effective Apr 27, 2026
scheduling
With the issuance of this final rule, the Drug Enforcement Administration places methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H- indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences
Notice · Comments due Jun 22, 2026
scheduling
AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: VA Cooperative Studies Program
Notice · Comments due May 21, 2026
scheduling
VA Cooperative Studies Program has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Leading Pharma LLC
Notice · Comments due May 21, 2026
scheduling
Leading Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Usona Institute, Inc.
Notice · Comments due Jun 16, 2026
scheduling
Usona Institute, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals
Notice · Comments due May 18, 2026
scheduling
Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Quagen Pharmaceuticals LLC
Notice · Comments due May 18, 2026
scheduling
Quagen Pharmaceuticals LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: LTS Therapy Systems, LLC
Notice · Comments due May 18, 2026
scheduling
LTS Therapy Systems, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Purisys, LLC
Notice · Comments due Jun 2, 2026
scheduling
Purisys, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute
Notice · Comments due Jun 2, 2026
scheduling
Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Lipomed/LGC Standards
Notice · Comments due May 4, 2026
scheduling
Lipomed/LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC
Notice · Comments due May 4, 2026
scheduling
Blue Rabbit Veterinary LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Designation of P2P Methyl Glycidic Acid as a List I Chemical
Final rule · Effective May 4, 2026
scheduling
The Drug Enforcement Administration is finalizing the control of 2-methyl-3-phenyloxirane-2-carboxylic acid (also known as P2P methyl glycidic acid and BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Research Triangle Institute
Notice · Comments due May 1, 2026
scheduling
Research Triangle Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Pharmaron Manufacturing Services (US) LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Sterling Wisconsin, LLC
Notice · Comments due May 1, 2026
scheduling
Sterling Wisconsin, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Indivior Manufacturing LLC
Notice · Comments due May 1, 2026
scheduling
Indivior Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due May 1, 2026
scheduling
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due May 1, 2026
scheduling
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals
Notice · Comments due Jun 1, 2026
scheduling
Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
Notice · Comments due Apr 29, 2026
scheduling
Pharmaron Manufacturing Services (US) LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Notice · Comments due May 29, 2026
scheduling
Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Usona Institute
Notice · Comments due Apr 29, 2026
scheduling
Usona Institute. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
Notice · Comments due May 26, 2026
scheduling
SpecGx LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Final rule · Effective Apr 22, 2026
scheduling
With the issuance of this final rule, the Drug Enforcement Administration places substance 3-methoxyphencyclidine (1-(1-(3- methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This…
Exempt Chemical Preparations Under the Controlled Substances Act
Notice · Comments due May 19, 2026
scheduling
The applications for exempt chemical preparations received by the Drug Enforcement Administration between September 1, 2024, and December 31, 2025, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations…
Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
Final rule · Effective Mar 20, 2026
scheduling
On September 30, 2019, the Drug Enforcement Administration (DEA) published the final rule, New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222). The final rule implemented a new single sheet format for DEA Form 222 and…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Pisgah Laboratories Inc
Notice · Comments due Apr 20, 2026
scheduling
Pisgah Laboratories Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: United States Pharmacopeial Convention
Notice · Comments due Apr 20, 2026
scheduling
United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Siegfried Grafton, Inc.
Notice · Comments due May 18, 2026
scheduling
Siegfried Grafton, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC
Notice · Comments due May 18, 2026
scheduling
Sterling Wisconsin, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Siegfried Grafton, Inc.
Notice · Comments due Apr 20, 2026
scheduling
Siegfried Grafton, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Patheon API Services, Inc.
Notice · Comments due Apr 20, 2026
scheduling
Patheon API Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: SpecGx LLC
Notice · Comments due Apr 20, 2026
scheduling
SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
Temporary scheduling order · Effective Mar 16, 2026
scheduling
The Drug Enforcement Administration issues this temporary order to schedule 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Patheon API Services Inc
Notice · Comments due May 12, 2026
scheduling
Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Lonza Tampa, LLC
Notice · Comments due Apr 13, 2026
scheduling
Lonza Tampa, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Pisgah Laboratories Inc
Notice · Comments due May 12, 2026
scheduling
Pisgah Laboratories Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Purisys, LLC
Notice · Comments due Apr 13, 2026
scheduling
Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Stepan Company
Notice · Comments due May 12, 2026
scheduling
Stepan Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Designation of Propionyl Chloride as a List I Chemical
Final rule · Effective Apr 9, 2026
scheduling
The Drug Enforcement Administration is finalizing the control of propionyl chloride as a list I chemical under the Controlled Substances Act (CSA). Propionyl chloride is used in the illicit manufacture of the controlled substances fentanyl, fentanyl analogues, and…
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals Inc.
Notice · Comments due May 11, 2026
scheduling
Sigma Aldrich Research Biochemicals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Developing Specifications for In-Home Disposal Systems for Opioid Analgesics Dispensed in an Outpatient Setting; Establishment of a Public Docket; Request for Comments
Notice · Comments due Apr 6, 2026
The Food and Drug Administration (FDA, the Agency, or we) is announcing the establishment of a docket to solicit public comment on what specifications for in-home disposal systems, if application holders are required to make them available under the Opioid Analgesic Risk…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Parexel International, LLC
Notice · Comments due Apr 3, 2026
scheduling
Parexel International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Maridose LLC
Notice · Comments due Apr 3, 2026
scheduling
Maridose LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Restek Corporation
Notice · Comments due May 4, 2026
scheduling
Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Patheon API Inc.
Notice · Comments due Apr 3, 2026
scheduling
Patheon API Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Stepan Company
Notice · Comments due Apr 3, 2026
scheduling
Stepan Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Restek Corporation
Notice · Comments due Apr 3, 2026
scheduling
Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Catalent Greenville, Inc.
Notice · Comments due Apr 3, 2026
scheduling
Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Amneal Pharmaceuticals, LLC
Notice · Comments due Apr 3, 2026
scheduling
Amneal Pharmaceuticals, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
Final rule · Effective Apr 1, 2026
scheduling
With the issuance of this final rule, the Drug Enforcement Administration places clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam and their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible…
International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Scheduling Recommendations; N-Pyrrolidino Isotonitazene; N-Desethyl Etonitazene; Coca Leaf; MDMB-FUBINACA; Request for Comments
Notice · Comments due Mar 5, 2026
scheduling
The Food and Drug Administration (FDA or Agency) is providing interested persons with the opportunity to submit written comments concerning recommendations to impose international manufacturing and distributing restrictions on certain drug substances, under international drug…
S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics, Inc.
Notice · Comments due Apr 14, 2026
scheduling
Siemens Healthcare Diagnostics, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Apr 14, 2026
scheduling
Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Apr 14, 2026
scheduling
Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017
Final rule · Effective Mar 9, 2026
scheduling
The "Protecting Patient Access to Emergency Medications Act of 2017," (the Act) which became law on November 17, 2017, amended the Controlled Substances Act (CSA) to allow for a new registration category for emergency medical services agencies that handle controlled substances. …
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: S & B Pharma LLC DBA Norac Pharma
Notice · Comments due Apr 6, 2026
scheduling
S & B Pharma LLC DBA Norac Pharma has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC
Notice · Comments due Apr 6, 2026
scheduling
Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Mylan Inc.
Notice · Comments due Mar 4, 2026
scheduling
Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthcare
Notice · Comments due Mar 4, 2026
scheduling
Medi-Physics Inc. DBA GE Healthcare has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Sharp Clinical Services, LLC
Notice · Comments due Mar 4, 2026
scheduling
Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Promega Corporation
Notice · Comments due Apr 3, 2026
scheduling
Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Organic Consultants, LLC DBA Cascade Chemistry has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Maridose LLC
Notice · Comments due Mar 24, 2026
scheduling
Maridose LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Siegfried USA, LLC
Notice · Comments due Feb 23, 2026
scheduling
Siegfried USA, LLC has applied to be registered as an importer of basic class(es) of controlled substances(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc.
Notice · Comments due Feb 20, 2026
scheduling
Mylan Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Notice of intent
pharma · scheduling
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one (commonly known as 2-fluorodeschloroketamine or 2-FDCK), including its salts, isomers, and salts…
Definition of “Cannabimimetic Agents” and Assignment of an Administration Controlled Substances Code Number for All “Cannabimimetic Agents”
Final rule · Effective Feb 19, 2026
scheduling
The Drug Enforcement Administration is publishing this final rule to amend its regulations related to "cannabimimetic agents" by including the term's definition, identifying 18 additional substances that meet the definition, and consolidating most existing administration…
Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
Notice · Comments due Mar 17, 2026
scheduling
Siegfried USA, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I
Final rule · Effective Feb 17, 2026
scheduling
With the issuance of this final rule, the Drug Enforcement Administration places 4-fluoroamphetamine (4-FA; 1-(4- fluorophenyl)propan-2-amine; para-fluoroamphetamine), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This…
Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
Final order · Effective Feb 11, 2026
scheduling
With the issuance of this final order, the Administrator of the Drug Enforcement Administration is permanently placing 2-(4- methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino metonitazene or metonitazepyne) and 5…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Mylan Technologies Inc.
Notice · Comments due Feb 9, 2026
scheduling
Mylan Technologies Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Curium US LLC
Notice · Comments due Feb 9, 2026
scheduling
Curium US LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Janssen Pharmaceuticals Inc.
Notice · Comments due Feb 9, 2026
scheduling
Janssen Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Feb 9, 2026
scheduling
AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026
Final order · Effective Jan 5, 2026
scheduling
This final order establishes the initial 2026 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
Final order · Effective Jan 22, 2026
scheduling
With the issuance of this final order, the Administrator of the Drug Enforcement Administration is permanently placing N-ethyl-2- (2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (other name: N-desethyl isotonitazene) and 2-(4-ethoxybenzyl)-5-nitro…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC
Notice · Comments due Feb 20, 2026
scheduling
IsoSciences LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Navinta LLC
Notice · Comments due Feb 20, 2026
scheduling
Navinta LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Myonex LLC
Notice · Comments due Jan 21, 2026
scheduling
Myonex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Jan 21, 2026
scheduling
National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Aveva Drug Delivery Systems, Inc.
Notice · Comments due Jan 20, 2026
scheduling
Aveva Drug Delivery Systems, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Bright Green Corporation
Notice · Comments due Jan 20, 2026
scheduling
Bright Green Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.
Notice · Comments due Feb 17, 2026
scheduling
Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Groff Health Inc.
Notice · Comments due Jan 20, 2026
scheduling
Groff Health Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Dec 12, 2025
scheduling
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA. The schedule I status of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA…
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
Notice of intent
scheduling
The Administrator of the Drug Enforcement Administration is issuing this notification of intent to publish a temporary order to schedule 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and…
Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Dec 12, 2025
scheduling
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of MDMB-4en-PINACA. The schedule I status of MDMB- 4en-PINACA is in effect through December 12, 2025. This temporary order will extend…
Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Dec 12, 2025
scheduling
The Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of CUMYL-PEGACLONE. In an order dated December 12, 2023, DEA temporarily placed CUMYL-PEGACLONE in schedule I of the Controlled…
Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Proposed rule · Comments due Jan 12, 2026
scheduling
The Drug Enforcement Administration proposes placing the substance CUMYL-PEGACLONE (SGT-151; 5-pentyl-2-(2-phenylpropan-2- yl)pyrido[4,3-b]indol-1-one), including its salts, isomers (including optical, positional, and geometric isomers), and salts of isomers, in schedule I of…
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Notice · Comments due Feb 2, 2026
scheduling
Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Invizyne Technologies, Inc.
Notice · Comments due Jan 30, 2026
scheduling
Invizyne Technologies, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Jan 30, 2026
scheduling
Benuvia Operations, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC
Notice · Comments due Dec 31, 2025
scheduling
Blue Rabbit Veterinary LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026
Notice
scheduling
The Drug Enforcement Administration (DEA) proposes to establish the 2026 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Noramco
Notice · Comments due Jan 26, 2026
scheduling
Noramco has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Noramco
Notice · Comments due Dec 26, 2025
scheduling
Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Jan 26, 2026
scheduling
National Center for Natural Products Research has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due Dec 26, 2025
scheduling
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Irvine Labs Inc.
Notice · Comments due Jan 26, 2026
scheduling
Irvine Labs Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Organix Chemistry Solutions, LLC
Notice · Comments due Jan 26, 2026
scheduling
Organix Chemistry Solutions, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Siegfried Grafton, Inc.
Notice · Comments due Jan 26, 2026
scheduling
Siegfried Grafton, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
Notice · Comments due Jan 26, 2026
scheduling
Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
Notice · Comments due Jan 26, 2026
scheduling
Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Jan 26, 2026
scheduling
Groff NA Hemplex LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Notice · Comments due Dec 26, 2025
scheduling
VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: NSI Lab Solutions, LLC.
Notice · Comments due Dec 26, 2025
scheduling
NSI Lab Solutions, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Caligor Coghlan Pharma Services
Notice · Comments due Dec 26, 2025
scheduling
Caligor Coghlan Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Siegfried Grafton, Inc.
Notice · Comments due Dec 26, 2025
scheduling
Siegfried Grafton, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Halo Pharmaceutical Inc.
Notice · Comments due Dec 26, 2025
scheduling
Halo Pharmaceutical Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Notice · Comments due Dec 26, 2025
scheduling
Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Dec 26, 2025
scheduling
Irvine Labs, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Jan 26, 2026
scheduling
Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Dec 26, 2025
scheduling
Benuvia Operations, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I
Final rule · Effective Dec 17, 2025
scheduling
With the issuance of this final rule, the Drug Enforcement Administration places 4-chloromethcathinone (4-CMC, 1-(4-chlorophenyl)- 2-(methylamino)propan-1-one), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is…
Schedules of Controlled Substances: Temporary Placement of Ethyleneoxynitazene, Methylenedioxynitazene, 5-Methyl Etodesnitazene, N-Desethyl Etonitazene, N-Desethyl Protonitazene, N,N-Dimethylamino Etonitazene, and N-Pyrrolidino Isotonitazene in Schedule I
Temporary scheduling order · Effective Oct 15, 2025
scheduling
The Drug Enforcement Administration issues this temporary order to schedule seven benzimidazole-opioids, as identified in this order, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing these substances in schedule I is necessary to…
Designation of P2P Methyl Glycidic Acid as a List I Chemical
Proposed rule · Comments due Nov 3, 2025
scheduling
The Drug Enforcement Administration is proposing the control of the chemical 2-methyl-3-phenyloxirane-2-carboxylic acid (also known as P2P methyl glycidic acid and BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and…
Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical
Final rule · Effective Oct 2, 2025
scheduling
The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Chemical Code Number for tert-butyl 4- oxopiperidine-1-carboxylate (also known as 1-boc-4-piperidone; and CAS Number: 79099-07-3) and its salts as a list I chemical under the Controlled…
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
Proposed rule · Comments due Nov 3, 2025
scheduling
The Drug Enforcement Administration proposes placing methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of…
Adjustment to the Aggregate Production Quota for d-Amphetamine (For Sale) and Methylphenidate (For Sale) for 2025 Pursuant to 21 U.S.C. 826(h)
Final order · Effective Oct 2, 2025
scheduling
The Drug Enforcement Administration (DEA) is adjusting the 2025 aggregate production quota for the schedule II-controlled substances d-amphetamine (for sale) and methylphenidate (for sale). In making this determination, DEA has considered the factors set forth in 21 CFR…
Controlled Substances Ordering System (CSOS) Modernization
Final rule · Effective Nov 3, 2025
scheduling
This rule is amending the Drug Enforcement Administration's (DEA) regulations to conform to the Controlled Substances Ordering System (CSOS) modernization effort by requiring all CSOS enrollment applications and supporting materials to be submitted through the Diversion Control…
Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated
Notice · Comments due Dec 1, 2025
scheduling
Cargill, Incorporated has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Oct 30, 2025
scheduling
Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Groff Health Inc
Notice · Comments due Nov 21, 2025
scheduling
Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2025 Pursuant to 21 U.S.C. 826(h)
Final order · Effective Sep 19, 2025
scheduling
The Drug Enforcement Administration (DEA) is adjusting the 2025 aggregate production quota for the schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion). In making this determination, DEA has considered the factors set forth in 21 CFR 1303.13(b)…
Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I
Final rule · Effective Sep 18, 2025
scheduling
The Drug Enforcement Administration places seven fentanyl- related substances, as identified in this final rule, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers in schedule I of the Controlled Substances Act. The regulatory controls and…
Importer of Controlled Substances Application: Catalent Greenville, Inc.
Notice · Comments due Oct 16, 2025
scheduling
Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Digital Health Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Generative Artificial Intelligence-Enabled Digital Mental Health Medical Devices
Notice
digital
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Digital Health Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA. The meeting will be open to the…
Importer of Controlled Substance Application: Fisher Clinical Services, Inc.
Notice · Comments due Oct 14, 2025
scheduling
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Notice · Comments due Oct 14, 2025
scheduling
Fresenius Kabi USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Notice · Comments due Nov 12, 2025
scheduling
Cambridge Isotope Laboratories, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Notice · Comments due Oct 14, 2025
scheduling
Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Notice · Comments due Oct 14, 2025
scheduling
Cambridge Isotope Laboratories, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Biopharmaceutical Research Company
Notice · Comments due Oct 14, 2025
scheduling
Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Development of Non-Opioid Analgesics for Chronic Pain, Draft Guidance for Industry; Availability
Notice · Comments due Nov 10, 2025
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Development of Non-Opioid Analgesics for Chronic Pain." This guidance is intended to assist sponsors in the development of non- opioid analgesics for the…
Importer of Controlled Substances Application: VA Cooperative Studies Program
Notice · Comments due Oct 8, 2025
scheduling
VA Cooperative Studies Program has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Continuus Pharmaceuticals
Notice · Comments due Oct 20, 2025
scheduling
Continuus Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Vici Health Sciences, LLC
Notice · Comments due Sep 22, 2025
scheduling
Vici Health Sciences, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Sep 22, 2025
scheduling
Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Catalent CTS, LLC
Notice · Comments due Sep 22, 2025
scheduling
Catalent CTS, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.
Notice · Comments due Oct 20, 2025
scheduling
Cambrex High Point, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Cambrex High Point, Inc.
Notice · Comments due Sep 22, 2025
scheduling
Cambrex High Point, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
Temporary scheduling order · Effective Aug 15, 2025
scheduling
The Drug Enforcement Administration issues this temporary order to schedule two benzimidazole-opioids in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing these substances in schedule I is necessary to avoid imminent hazard to public…
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Oct 14, 2025
scheduling
Benuvia Operations, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company
Notice · Comments due Oct 10, 2025
scheduling
Biopharmaceutical Research Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals
Notice · Comments due Oct 10, 2025
scheduling
Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Experic LLC
Notice · Comments due Sep 10, 2025
scheduling
Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Chattem Chemicals
Notice · Comments due Sep 10, 2025
scheduling
Chattem Chemicals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Sep 10, 2025
scheduling
Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Oct 10, 2025
scheduling
Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Curia New York Inc
Notice · Comments due Sep 10, 2025
scheduling
Curia New York Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc
Notice · Comments due Sep 10, 2025
scheduling
Galephar Pharmaceutical Research Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc.
Notice · Comments due Sep 10, 2025
scheduling
Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance
Final rule · Effective Aug 8, 2025
scheduling
The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (dipentylone; N,N-dimethylpentylone) in schedule I of the Controlled Substances Act (CSA).
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Notice · Comments due Oct 7, 2025
scheduling
Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Jul 26, 2025
scheduling
The Acting Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of five designer benzodiazepines--clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam. In an order dated…
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
Proposed rule · Comments due Aug 25, 2025
scheduling
The Drug Enforcement Administration proposes placing clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam and their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Cerilliant Corporation
Notice · Comments due Aug 18, 2025
scheduling
Cerilliant Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals LLC
Notice · Comments due Sep 15, 2025
scheduling
AMPAC Fine Chemicals LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Aug 18, 2025
scheduling
AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
Notice · Comments due Sep 15, 2025
scheduling
Cerilliant Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Curia New York, Inc.
Notice · Comments due Sep 15, 2025
scheduling
Curia New York, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Curia Missouri Inc.
Notice · Comments due Sep 15, 2025
scheduling
Curia Missouri Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Exempt Chemical Preparations Under the Controlled Substances Act
Notice · Comments due Sep 2, 2025
scheduling
The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2023, and March 31, 2025, as listed below, were accepted for filing and have been approved or denied as indicated.
Schedules of Controlled Substances: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I
Notice of intent
scheduling
The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule seven benzimidazole-opioid substances in schedule I of the Controlled Substances Act. When it is finalized, the temporary scheduling order…
Importer of Controlled Substances Application: Arizona Department of Corrections
Notice · Comments due Jul 24, 2025
scheduling
Arizona Department of Corrections has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Jul 18, 2025
scheduling
Veranova, L.P. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem
Notice · Comments due Aug 18, 2025
scheduling
American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Jul 18, 2025
scheduling
AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Aug 18, 2025
scheduling
Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances AJNA Biosciences
Notice · Comments due Aug 18, 2025
scheduling
AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I
Proposed rule · Comments due Jul 10, 2025
scheduling
The Drug Enforcement Administration proposes placing 3- methoxyphencyclidine, including its salts, isomers, and salts of isomers, an arylcyclohexylamine hallucinogen, in schedule I of the Controlled Substances Act. This action is proposed to enable the United States to meet its…
Schedules of Controlled Substances: Placement of Three Specific Fentanyl-Related Substances in Schedule I
Proposed rule · Comments due Jul 10, 2025
scheduling
The Drug Enforcement Administration proposes placing three fentanyl-related substances, as identified in this proposed rule, in schedule I of the Controlled Substances Act. These three substances fall within the definition of fentanyl-related substances set forth in the…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Usona Institute, Inc
Notice · Comments due Aug 4, 2025
scheduling
Usona Institute, Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc.
Notice · Comments due Aug 4, 2025
scheduling
ANI Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Special Surveillance List of Chemicals, Products, Materials and Equipment Used in the Manufacture of Controlled Substances and Listed Chemicals
Notice
scheduling
The Controlled Substances Act provides for civil penalties for the distribution of a laboratory supply to a person who uses, or attempts to use, that laboratory supply to manufacture a controlled substance or a listed chemical, if that distribution was made with reckless…
Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I; Correction
Correction · Correction effective Jun 3, 2025
scheduling
On March 15, 2024, the Drug Enforcement Administration published a final order placing 1-(2-methyl-4-(3-phenylprop-2-en-1- yl)piperazin-1-yl)butan-1-one (commonly known as 2-methyl AP-237), including its optical and geometric isomers, esters, ethers, salts, and salts of…
Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I
Proposed rule · Comments due Jul 3, 2025
scheduling
The Drug Enforcement Administration proposes placing the substance 4-fluoroamphetamine (4-FA; 1-(4-fluorophenyl)propan-2-amine), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable…
Designation of Propionyl Chloride as a List I Chemical
Proposed rule · Comments due Jul 3, 2025
scheduling
The Drug Enforcement Administration is proposing the control of propionyl chloride as a list I chemical under the Controlled Substances Act (CSA). The Drug Enforcement Administration finds that propionyl chloride is used in the illicit manufacture of the controlled substances…
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Aug 1, 2025
scheduling
Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
Notice · Comments due Jul 2, 2025
scheduling
ANI Pharmaceuticals Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Quagen Pharmaceuticals LLC
Notice · Comments due Jun 20, 2025
scheduling
Quagen Pharmaceuticals LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Usona Institute
Notice · Comments due Jun 20, 2025
scheduling
Usona Institute. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Patheon API Inc.
Notice · Comments due Jun 20, 2025
scheduling
Patheon API Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Research Triangle Institute
Notice · Comments due Jun 13, 2025
scheduling
Research Triangle Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Pall Life Sciences PR, LLC
Notice · Comments due Jun 13, 2025
scheduling
Pall Life Sciences PR, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
Notice · Comments due Jun 13, 2025
scheduling
Wedgewood Pharmacy LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: United States Pharmacopeial Convention
Notice · Comments due Jun 2, 2025
scheduling
United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Unither Manufacturing LLC
Notice · Comments due Jun 2, 2025
scheduling
Unither Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Almac Clinical Services Inc (ASCI)
Notice · Comments due May 28, 2025
scheduling
Almac Clinical Services, Inc., (ACSI) has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Lipomed
Notice · Comments due May 28, 2025
scheduling
Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc.
Notice · Comments due Jun 27, 2025
scheduling
Siemens Healthcare Diagnostics, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
The Drug Enforcement Administration (DEA) published a document in the Federal Register on March 26, 2025, concerning a notice of application for bulk manufacturer of Controlled Substances. As that document indicated the registrant's incorrect plans for the listed controlled…
Bulk Manufacturer of Controlled Substances Application: Pisgah Laboratories Inc
Notice · Comments due Jun 27, 2025
scheduling
Pisgah Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Notice · Comments due May 28, 2025
scheduling
VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Skalar Pharma LLC
Notice · Comments due May 28, 2025
scheduling
Skalar Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals
Notice · Comments due May 27, 2025
scheduling
Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
Notice · Comments due Jun 24, 2025
scheduling
SpecGx LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee; Amendment of Notice-Extended-Release/Long-Acting Opioid Analgesic Postmarketing Requirement
Notice
The Food and Drug Administration (FDA) is announcing an amendment to the notice of joint meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee. This meeting was announced in the Federal Register of…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Myonex LLC
Notice · Comments due May 19, 2025
scheduling
Myonex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Restek Corporation
Notice · Comments due Jun 17, 2025
scheduling
Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Patheon API Services Inc.
Notice · Comments due Jun 17, 2025
scheduling
Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Stepan Company
Notice · Comments due Jun 17, 2025
scheduling
Stepan Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due May 19, 2025
scheduling
Scottsdale Research Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Research Triangle Institute
Notice · Comments due Jun 17, 2025
scheduling
Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application; Promega Corporation
Notice · Comments due May 27, 2025
scheduling
Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Restek Corporation
Notice · Comments due Apr 28, 2025
scheduling
Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Royal Beverages, LLC
Notice · Comments due May 27, 2025
scheduling
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending…
Importer of Controlled Substances Application: Patheon API Services, Inc.
Notice · Comments due Apr 28, 2025
scheduling
Patheon API Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals
Notice · Comments due May 27, 2025
scheduling
Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: SpecGx LLC
Notice · Comments due Apr 28, 2025
scheduling
SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Ohana Bio Pharma, LLC
Notice · Comments due May 27, 2025
scheduling
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending…
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Baxter Research Lab
Notice · Comments due May 27, 2025
scheduling
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Maridose LLC (I)
Notice · Comments due Apr 25, 2025
scheduling
Maridose, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: SpecGx LLC
Notice · Comments due Apr 25, 2025
scheduling
SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
Notice · Comments due Apr 25, 2025
scheduling
Pharmaron Manufacturing Services (US) LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Pharmaron Manufacturing Services (US), LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC
Notice · Comments due May 27, 2025
scheduling
Sterling Wisconsin, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substance Application: Fisher Clinical Services, Inc.
Notice · Comments due Apr 16, 2025
scheduling
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC
Notice · Comments due May 16, 2025
scheduling
Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due Apr 14, 2025
scheduling
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc.
Notice · Comments due May 12, 2025
scheduling
Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals Inc.
Notice · Comments due May 12, 2025
scheduling
Sigma Aldrich Research Biochemicals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Meridian Medical Technologies, LLC
Notice · Comments due Apr 14, 2025
scheduling
Meridian Medical Technologies, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Stepan Company
Notice · Comments due Apr 9, 2025
scheduling
Stepan Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: LTS Therapy Systems, LLC
Notice · Comments due Apr 7, 2025
scheduling
LTS Therapy Systems, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Aphena Pharma Solutions MD, LLC
Notice · Comments due Apr 7, 2025
scheduling
Aphena Pharma Solutions MD, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Indivior Inc.
Notice · Comments due Apr 7, 2025
scheduling
Indivior Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Apr 28, 2025
scheduling
Groff Hemplex LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Notice · Comments due Mar 28, 2025
scheduling
Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Sharp Clinical Services, LLC
Notice · Comments due Mar 28, 2025
scheduling
Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.
Notice · Comments due Apr 21, 2025
scheduling
Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Apr 21, 2025
scheduling
Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Notice · Comments due Apr 21, 2025
scheduling
Patheon API Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Lonza Tampa, LLC
Notice · Comments due Mar 20, 2025
scheduling
Lonza Tampa, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Apr 21, 2025
scheduling
Scottsdale Research Institute, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Mylan Pharmaceuticals, Inc.
Notice · Comments due Mar 20, 2025
scheduling
Mylan Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Purisys, LLC
Notice · Comments due Apr 21, 2025
scheduling
Purisys, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Purisys, LLC
Notice · Comments due Mar 17, 2025
scheduling
Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Janssen Pharmaceuticals Inc.
Notice · Comments due Mar 17, 2025
scheduling
Janssen Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Mar 17, 2025
scheduling
Veranova, L.P. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Maridose LLC
Notice · Comments due Apr 14, 2025
scheduling
Maridose LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: University of Kentucky Cannabis Center
Notice · Comments due Apr 14, 2025
cannabis · scheduling
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending…
Importer of Controlled Substances Application: Mylan Inc.
Notice · Comments due Mar 17, 2025
scheduling
Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Apr 14, 2025
scheduling
Benuvia Operations, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthcare
Notice · Comments due Mar 3, 2025
scheduling
Medi-Physics Inc. DBA GE Healthcare has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Catalent Greenville, Inc.
Notice · Comments due Mar 3, 2025
scheduling
Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Organic Consultants LLC DBA Cascade Chemistry has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Vici Health Sciences, LLC
Notice · Comments due Feb 27, 2025
scheduling
Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Aveva Drug Delivery Systems, Inc.
Notice · Comments due Feb 27, 2025
scheduling
Aveva Drug Delivery Systems, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Mar 25, 2025
scheduling
Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Noramco
Notice · Comments due Mar 25, 2025
scheduling
Noramco has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Notice · Comments due Feb 24, 2025
scheduling
VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
Notice · Comments due Mar 24, 2025
scheduling
Siegfried USA, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Groff Health, Inc.
Notice · Comments due Mar 24, 2025
scheduling
Groff Health, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Invizyne Technologies, Inc.
Notice · Comments due Mar 24, 2025
scheduling
Invizyne Technologies, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Special Registrations for Telemedicine and Limited State Telemedicine Registrations
Proposed rule
digital · scheduling
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the "Ryan Haight Act") generally requires an in-person medical evaluation prior to the issuance of a prescription of controlled substances but provides an exception to this in-person medical evaluation requirement…
Expansion of Buprenorphine Treatment via Telemedicine Encounter
Final rule · Effective Feb 18, 2025
digital · scheduling
The Drug Enforcement Administration and the Department of Health and Human Services are amending their regulations to expand the circumstances under which practitioners registered by the Drug Enforcement Administration are authorized to prescribe schedule III-V controlled…
Continuity of Care via Telemedicine for Veterans Affairs Patients
Final rule · Effective Feb 18, 2025
digital · scheduling
This final rule authorizes Department of Veterans Affairs (VA) practitioners acting within the scope of their VA employment to prescribe controlled substances via telemedicine to a VA patient with whom they have not conducted an in-person medical evaluation. VA practitioners…
Use of Cannabis-Derived Products, Including Cannabidiol, in Veterinary Practice; Request for Information
Notice · Comments due Apr 16, 2025
cannabis
The Food and Drug Administration (FDA, the Agency, or we) is soliciting comments from the public, particularly veterinarians, related to the use of cannabis-derived products (CDPs) in animals, with an emphasis on cannabidiol (CBD) products and general trends associated with…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Siegfried USA, LLC
Notice · Comments due Jan 29, 2025
scheduling
Siegfried USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Irvine Labs Inc.
Notice · Comments due Feb 28, 2025
scheduling
Irvine Labs Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Curia New York, Inc.
Notice · Comments due Jan 29, 2025
scheduling
Curia New York, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Extension of Temporary Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Dec 31, 2024
scheduling
The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of seven specific fentanyl-related substances, as identified in this order, including their isomers, esters, ethers, salts, and salts of…
Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I
Proposed rule · Comments due Jan 29, 2025
scheduling
The Drug Enforcement Administration proposes placing seven fentanyl-related substances, as identified in this proposed rule, in schedule I of the Controlled Substances Act. These seven substances fall within the definition of fentanyl-related substances set forth in the…
Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I
Proposed rule · Comments due Jan 29, 2025
scheduling
The Drug Enforcement Administration proposes placing the substance 4-chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2- (methylamino)propan-1-one), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in…
Modifications to Labeling of Buprenorphine-Containing Transmucosal Products for the Treatment of Opioid Dependence
Notice
The Food and Drug Administration (FDA, Agency, or we) is announcing that we have concluded that certain statements set forth in the FDA-approved labeling for buprenorphine-containing transmucosal products for the treatment of opioid dependence (BTODs) related to the recommended…
Importer of Controlled Substances Application: Leading Pharma LLC
Notice · Comments due Jan 17, 2025
scheduling
Leading Pharma LLC to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025
Final order · Effective Dec 17, 2024
scheduling
This final order establishes the initial 2025 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024
Final order · Effective Dec 17, 2024
scheduling
This final order establishes the final adjusted 2024 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Jan 13, 2025
scheduling
Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Feb 11, 2025
scheduling
National Center for Natural Products Research has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Extended-Release/Long-Acting Opioid Analgesic Postmarketing Requirement
Notice
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee (the Committees). The general function of the Committees…
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Noramco
Notice · Comments due Jan 6, 2025
scheduling
Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Navinta LLC
Notice · Comments due Feb 4, 2025
scheduling
Navinta LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Notice · Comments due Jan 6, 2025
scheduling
Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Notice · Comments due Feb 4, 2025
scheduling
Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Dec 30, 2024
scheduling
Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Curia Wisconsin, Inc.
Notice · Comments due Dec 30, 2024
scheduling
Curia Wisconsin, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Dec 26, 2024
scheduling
National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Isosciences, LLC
Notice · Comments due Jan 27, 2025
scheduling
Isosciences, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Organix Chemistry Solutions, LLC
Notice · Comments due Jan 27, 2025
scheduling
Organix Chemistry Solutions, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Experic LLC
Notice · Comments due Dec 26, 2024
scheduling
Experic LLC to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
Notice · Comments due Jan 27, 2025
scheduling
Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works. The date shown is the day ClinicalTrials.gov first posted it.
No clinical-trial registrations meet this tracker’s selection criteria for the selected period. ClinicalTrials.gov was last checked successfully on Nov 17, 2026.
First posted November 17, 2026
Registration
Anxiety Reduction, Learning Support, Mood, and Self-efficacy Adaptation in Families With Healthy Newborns
Status at last check: Not yet recruiting · NCT07943936
ClinicalTrials.gov registration NCT07943936 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Can Spending Time in Nature Help Mothers With Depression After Childbirth? A 6-Week Forest Therapy Study
Status at last check: Enrolling by invitation · NCT07943858
Postpartum Depression, Postpartum Depression (PPD), Postnatal Depression — Forest Therapy Group, Standard Care (in control arm)
ClinicalTrials.gov registration NCT07943858 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Ketamine for Treatment of Alzheimers Disease Related Depression
Status at last check: Not yet recruiting · NCT07943741
Late Life Depression (LLD), MCI, MCI-AD, Early Stage Alzheimer's Disease — Ketamine and saline, Active Placebo (Midazolam) Infusion
ClinicalTrials.gov registration NCT07943741 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07943624 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Mechanisms and Interventions of Treatment-Resistant Schizophrenia Based on Brain Organoids
Status at last check: Not yet recruiting · NCT07943559
Treatment-resistant Schizophrenia
ClinicalTrials.gov registration NCT07943559 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Addressing Violence in the Context of Opioid Use Disorder Care
Status at last check: Not yet recruiting · NCT07943455
Sexual Violence, Opioid Use Disorder, Posttraumatic Stress Disorder — SHE-OUD
ClinicalTrials.gov registration NCT07943455 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07943130 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ADHD - Attention Deficit Disorder With Hyperactivity
ClinicalTrials.gov registration NCT07942467 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Effects of Prayer on Psychological, Physical, and Spiritual Well-being in Adults With Cancer: A Pilot Study
Status at last check: Completed · NCT07942454
Depressive Symptoms, Anxiety Symptoms, Pain, Quality of Life — Prayer
ClinicalTrials.gov registration NCT07942454 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07942441 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Healing and Improving Postnatal Nights Through Sleep (HIPNoS)
Status at last check: Not yet recruiting · NCT07942246
Insomnia, Depression — Perinatal Understanding of Mindful Awareness for Sleep (PUMAS), Sleep Hygiene Education (SHE)
ClinicalTrials.gov registration NCT07942246 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07942064 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07941986 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07941895 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07941882 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07941817 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07941804 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07941687 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Exploring the Efficacy and Mechanism of Accelerated High-Definition Transcranial Direct Current Stimulation (HD-tDCS) in the Treatment of Obsessive-compulsive Disorder
Status at last check: Not yet recruiting · NCT07940816
Obsessive Compulsive Disorder (OCD) — high-definition transcranial direct current stimulation (HD-tDCS), sham HD-tDCS
ClinicalTrials.gov registration NCT07940816 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Cognitive Augmentation, Remediation, and TDCS for Schizophrenia
Status at last check: Not yet recruiting · NCT07940712
Schizophrenia / Schizoaffective Disorder — High-definition transcranial direct current stimulation, Cognitive remediation therapy, Sham cognitive remediation therapy
ClinicalTrials.gov registration NCT07940712 · first posted Nov 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effect of a Video-based Information Intervention on Family Outcomes in Neurocritical Care
Status at last check: Not yet recruiting · NCT07940218
Post-traumatic Stress Symptoms, Depression Anxiety Disorder — Educational videos, Usual family support
ClinicalTrials.gov registration NCT07940218 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07939698 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Study of Neurorehabilitation for Substance Use Disorder
Status at last check: Completed · NCT07939542
Cannabis Use Disorder — Transcranial Direct Current Stimulation (Active), Sham Transcranial Direct Current Stimulation
ClinicalTrials.gov registration NCT07939542 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Multitarget HD-tDCS and Spatial Navigation Memory in Schizophrenia
Status at last check: Completed · NCT07939477
Schizophrenia — Active Multitarget HD-tDCS, Sham HD-tDCS
ClinicalTrials.gov registration NCT07939477 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
AVATAR Therapy for Distressing Voices in India and Ethiopia
Status at last check: Not yet recruiting · NCT07939347
Psychosis, Hallucinations — AVATAR Therapy
ClinicalTrials.gov registration NCT07939347 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07939178 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Preventing Mood Disorders in High-risk Offspring: Protocol for the Randomized Controlled Trial of the MARIO Online Preventive Intervention Platform
Status at last check: Recruiting · NCT07938593
Mood Disorders, Mood Disorders in Children and Adolescents, Depressive Symptoms, Mania, Resilience, Psychological, Bipolar Disorder (BD) — KOPPsupport, Moodpep, Grow It!
ClinicalTrials.gov registration NCT07938593 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07938372 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Sotatercept in the Treatment of Methamphetamine-Associated Pulmonary Arterial Hypertension
Status at last check: Not yet recruiting · NCT07938294
Pulmonary Arterial Hypertension (PAH), Methamphetamine Use Disorder — Sotatercept
ClinicalTrials.gov registration NCT07938294 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07938177 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Effect of Social Cognition and Interaction Training on Patients With Schizophrenia
Status at last check: Completed · NCT07938047
SCHIZOPHRENIA — the social cognition and interaction training
ClinicalTrials.gov registration NCT07938047 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry-Guided Breathing Therapy - Phase 2
Status at last check: Not yet recruiting · NCT07937865
Written Exposure Therapy, Breathing Techniques, PTSD (Childbirth-Related), Postpartum Care — Written Exposure Therapy (WET), Capnometry-Guided Breathing Intervention (CGRI)
ClinicalTrials.gov registration NCT07937865 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Traditional Chinese Medicine Augmentation Therapy for Obsessive-Compulsive Disorder
Status at last check: Not yet recruiting · NCT07937774
Obsessive-Compulsive Disorder, OCD, Traditional Chinese Medicine (TCM), Therapy, Non, Nonrespond — Chaixia Dingzhi Powder, Placebo Group
ClinicalTrials.gov registration NCT07937774 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effects of Painting-Based Art Interventions in Individuals With Schizophrenia
Status at last check: Completed · NCT07937761
Schizophrenia — Painting-Based Art Intervention
ClinicalTrials.gov registration NCT07937761 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effect of Clinical Pharmacist-Led Pharmaceutical Care in Major Depressive Disorder
Status at last check: Completed · NCT07937644
Major Depressive Disorder (MDD), Medication Adherence — Clinical Pharmacist-Led Pharmaceutical Care
ClinicalTrials.gov registration NCT07937644 · first posted Nov 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
CYOA App Intervention for Social Media Use in Adolescents With Depression
Status at last check: Not yet recruiting · NCT07936890
Major Depressive Disorder, Depression, Adolescent Depression, Problematic Social Media Use — Choose Your Own Adventure App
ClinicalTrials.gov registration NCT07936890 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Mindfulness Program for Blood Sugar Control, Heart Rate Variability, Anxiety, and Depression in Type 2 Diabetes
Status at last check: Completed · NCT07936357
Type 2 Diabetes Mellitus, Diabetic Autonomic Neuropathy, Anxiety, Depression — Six-week audio-guided mindfulness program
ClinicalTrials.gov registration NCT07936357 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Nurse-Led Simulation-Based Prosocial Skills Training in Individuals With Schizophrenia
Status at last check: Completed · NCT07936149
SCHIZOPHRENIA 1 (Disorder) — Nurse-Led Simulation-Based Prosocial Skills Training
ClinicalTrials.gov registration NCT07936149 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Melodies for Mums to Be: Community Group Singing Intervention for Pregnant Women With Antenatal Depressive Symptoms
Status at last check: Not yet recruiting · NCT07935824
Antenatal Depression — Melodies for Mums to Be, Usual Care
ClinicalTrials.gov registration NCT07935824 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07935746
Schizophrenia Disorder — Active 4.5Hz θ tACS Stimulation, Active 6Hz θ tACS Stimulation, sham tACS Stimulation
ClinicalTrials.gov registration NCT07935746 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07935096 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Written Exposure Therapy for Childbirth-related Post-Traumatic Stress
Status at last check: Recruiting · NCT07935070
PTSD (Childbirth-Related), PTSD - Post Traumatic Stress Disorder, PTSD — Written Exposure Therapy
ClinicalTrials.gov registration NCT07935070 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Efficacy and Neural Mechanisms of Individualized Neuromodulation Combined With Think/No-Think Training in Individuals With Internalizing Disorders
Status at last check: Not yet recruiting · NCT07935005
Anxiety, Depression Disorder, OCD, PTSD, CPTSD, Compelx Post-traumatic Stress Disorder — Individualized Transcranial Alternating Current Stimulation (tACS), Individualized Temporal Interference Stimulation (TIS), Autobiographical Think/No-Think Thought Suppression Training
ClinicalTrials.gov registration NCT07935005 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07934784
Depression — Physical touch
ClinicalTrials.gov registration NCT07934784 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07934706
Suicide, Firearm Injury — SecureHomes, Health and Stress Counseling
ClinicalTrials.gov registration NCT07934706 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Mental Health Link for Veterans Referred to Mental Health Services
Status at last check: Not yet recruiting · NCT07934680
Depression — Mental Health Link
ClinicalTrials.gov registration NCT07934680 · first posted Nov 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Exploring Ketamine's Effects on Depression and Anxiety in Adults With Low Vision
Status at last check: Not yet recruiting · NCT07934043
Depression, Anxiety, Low Vision — Ketamine
ClinicalTrials.gov registration NCT07934043 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Implementing an Evidence-based Alcohol Use and Sexual Risk Intervention in Young Adult Homeless Service Settings
Status at last check: Not yet recruiting · NCT07933406
Alcohol Consumption, Alcohol Use Disorder (AUD), Substance Use (Drugs, Alcohol), Substance Use Disorder (SUD), Condomless Sex, Unprotected Sex, High-risk Sex — AWARE
ClinicalTrials.gov registration NCT07933406 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Predicting Transitions From Depression to Wellbeing Through a Network-based Operationalization of Plasticity
Status at last check: Not yet recruiting · NCT07933276
Major Depressive Disorder (MDD) — Clinical and cognitive assessments, Multimodal MRI, Blood sampling for multi-omic analyses
ClinicalTrials.gov registration NCT07933276 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Efficacy of Vaped Cannabidiol in Cannabis Use Disorder
Status at last check: Not yet recruiting · NCT07933081
Cannabis Use Disorder — CBD vape liquid, Placebo Liquid
ClinicalTrials.gov registration NCT07933081 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07932236 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Unveiling Maternal-fetal BRAin-body Interactions in Pregnant WOmen Affected by Depression
Status at last check: Recruiting · NCT07932093
Depression in Pregnancy, Major Depressive Disorder, Pregnancy — Multimodal MRI and EEG-ECG/PPG recordings, Biological sampling, Clinical and neurodevelopmental assessments
ClinicalTrials.gov registration NCT07932093 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Electrical Brain Stimulation for College Students With Short-Form Video Addiction: Effects and Mechanisms
Status at last check: Not yet recruiting · NCT07931729
Short-form Video Addiction — Active High-Definition Transcranial Direct Current Stimulation (Active HD-tDCS), Sham High-Definition Transcranial Direct Current Stimulation (Sham HD-tDCS)
ClinicalTrials.gov registration NCT07931729 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Safety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE)
Status at last check: Not yet recruiting · NCT07931703
Social Anxiety Disorder — RGH-202, Placebo
ClinicalTrials.gov registration NCT07931703 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
STRIVES: Status-Neutral TeleHealth Concierge Intervention for Unhoused People Who Use Drugs Via Engagement Through Street Medicine
Status at last check: Not yet recruiting · NCT07931612
HIV, Substance Use Disorder (SUD), HEPATITIS C (HCV), Homelessness — Standard of Care (Patient Navigation to Off-Site Clinic), Status-Neutral Telehealth Concierge (SN-THR)
ClinicalTrials.gov registration NCT07931612 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Mild Cognitive Impairment in Older Adults With and Without Depressive Symptom
Status at last check: Not yet recruiting · NCT07931586
Mild Cognitive Impairment (MCI), Depression and Anxiety Symptoms
ClinicalTrials.gov registration NCT07931586 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Health Assessment in People With Severe Mental Illness
Status at last check: Recruiting · NCT07931456
Severe Mental Illness, Schizophrenia, Bipolar Disorder, Depression / Major Depressive Disorder
ClinicalTrials.gov registration NCT07931456 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Nature-Based Exercise for Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07931443
Major Depressive Disorder (MDD) — Nature-Based Combined Exercise Program, Indoor Combined Exercise Program, Usual Mental Healthcare and Occupational Activities
ClinicalTrials.gov registration NCT07931443 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Peer Recovery Support in the Homeless Health Care Setting
Status at last check: Not yet recruiting · NCT07931430
Opioid Use Disorder — Peer support
ClinicalTrials.gov registration NCT07931430 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Dental Phobia, Dental Anxiety in Children, Dental Fear, Dental Fear and Anxiety — One-Session Treatment for Dental Phobia (OSTD), Psychoeducation and Relaxation Training (RELAX)
ClinicalTrials.gov registration NCT07931131 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07931079 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Longitudinal Assessment of Biomarkers Among Patients With MDD
Status at last check: Recruiting · NCT07931001
Major Depressive Disorder (MDD) — No Intervention: Observational Cohort
ClinicalTrials.gov registration NCT07931001 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07930871 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07930819 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Peer-Support Cognitive Behavioral Intervention for Military Life Transitions (Mil-iTransition)
Status at last check: Completed · NCT07930234
Peer-Support Intervention, Military-to-Civilian Transition, Medical Disability, Suicide Prevention, Pilot Randomized Controlled Trial — Telephone- Based Peer Support + TAU
ClinicalTrials.gov registration NCT07930234 · first posted Nov 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07930000 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluation of the EPDS and PC-PTSD-5 Scales for Screening Postpartum Mental Health Disorders Among Migrant Women.
Status at last check: Not yet recruiting · NCT07929272
Post Partum Depression — psychiatric interview
ClinicalTrials.gov registration NCT07929272 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Project Raising Exposure Awareness for Caregiver Help-Seeking
Status at last check: Not yet recruiting · NCT07929077
Anxiety, Obsessive Compulsive Disorder (OCD), Trauma and Stress Related Disorders — Tailored Dissemination Campaign, Dissemination-as-usual
ClinicalTrials.gov registration NCT07929077 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Virtual Reality vs. Gym-Based Martial Arts Training for Aggression in Children With Conduct Disorder
Status at last check: Completed · NCT07929025
Conduct Disorder, Externalizing Behavior, Child Mental Health — Immersive VR-Based Martial Arts Training, Club-Based Martial Arts Training
ClinicalTrials.gov registration NCT07929025 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Transcranial Magnetic Therapy (TMS) for Treatment of Perinatal Depression
Status at last check: Active, not recruiting · NCT07928908
Perinatal Depression — Transcranial Magnetic Stimulation (TMS)
ClinicalTrials.gov registration NCT07928908 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Low Intensity Focused Ultrasound in Cocaine Use Disorder
Status at last check: Not yet recruiting · NCT07928648
Cocaine Use Disorder (CUD) — Low Intensity Focused Ultrasound
ClinicalTrials.gov registration NCT07928648 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Mentalization Orientated Psychoeducation Group for Adult ADHD (MOPAD)
Status at last check: Not yet recruiting · NCT07928440
ADHD - Attention Deficit Disorder With Hyperactivity — The MOPAD study tests whether an introductory Mentalization-Based Treatment (iMBT)
ClinicalTrials.gov registration NCT07928440 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07928310 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study of Brenipatide in Participants With Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07928245
Major Depressive Disorder — Brenipatide, Placebo
ClinicalTrials.gov registration NCT07928245 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07927946 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07927790 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Decentralized, Status Neutral, Stakeholder-engaged, Post-incarceration Intervention for People Living With and at Risk for HIV
Status at last check: Not yet recruiting · NCT07927673
Substance Use Disorder (SUD), HIV (Human Immunodeficiency Virus), Viral Suppression of HIV Infection — DEST2nation model, Standard of care referral
ClinicalTrials.gov registration NCT07927673 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07927504 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Medical Nitrous Oxide Combined With Personalized Traumatic Script Exposure for the Treatment of Post-Traumatic Stress Disorder
Status at last check: Not yet recruiting · NCT07927192
PTSD - Post Traumatic Stress Disorder — MEOPA (Nitrous Oxide/Oxygen Premix), Medical Air in Oxygen, Personalized Traumatic Script Exposure
ClinicalTrials.gov registration NCT07927192 · first posted Nov 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07927036 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07926776 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Community Context and Psychological Flexibility in Residential Substance Use Treatment: A Longitudinal Sequential Mediation Study
Status at last check: Active, not recruiting · NCT07926750
Substance-Related Disorders, Substance Use Disorders — Routine residential therapeutic community treatment (not assigned by the study)
ClinicalTrials.gov registration NCT07926750 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Trauma-related PTSD, Anxiety and Distress, Depression — Healing Trauma Plus (HT+): A Brief Intervention for Women and Gender-Diverse People
ClinicalTrials.gov registration NCT07926568 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07925762 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Mediating Role of Social Support and Self-Esteem in the Effect of Physical Activity on the Mental Health of University Students
Status at last check: Completed · NCT07925346
Depression, Life Satisfaction
ClinicalTrials.gov registration NCT07925346 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Emotional Reactivity in Severe Alcohol Use Disorder and Major Depressive Disorder Using Eye-tracking, Physiological, and Interoceptive Measures (ERAD)
Status at last check: Recruiting · NCT07925281
Alcohol Use Disorder, Major Depressive Disorder (MDD) — Emotional Reactivity Experimental Protocol
ClinicalTrials.gov registration NCT07925281 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Prevalence and Factors Associated With Depression Among Children and Adolescents With Type 1 Diabetes Mellituss
Status at last check: Not yet recruiting · NCT07925164
Depression in Type 1 Diabetes Mellituss — Observation follow-up
ClinicalTrials.gov registration NCT07925164 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Individualized Temporal Interference Stimulation for Reward Processing in Late-Life Depression
Status at last check: Not yet recruiting · NCT07925047
Major Depressive Disorder (MDD — Active Temporal Interference Stimulation, Sham Temporal Interference Stimulation
ClinicalTrials.gov registration NCT07925047 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Individualized Temporally Interfering Electrical Stimulation in Major Depressive Disorder
Status at last check: Recruiting · NCT07924917
Major Depressive Disorder (MDD) — Single-target active temporally interfering electrical stimulation, Dual-target active temporally interfering electrical stimulation, Sham temporally interfering electrical stimulation
ClinicalTrials.gov registration NCT07924917 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Neuromodulation of Motivation and Reward Oscillations
Status at last check: Recruiting · NCT07924852
Cannabis Use Disorder, Major Depression, Anhedonia, Transcranial Alternating Current Stimulation — Transcranial Alternating Current Stimulation Sham, Transcranial Alternating Current Delta Stimulation., Transcranial Alternating Current Theta Stimulation
ClinicalTrials.gov registration NCT07924852 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study of Remission Criteria in Anorexia Nervosa: A Multidimensional Exploratory Observational Study of Recovery Among Patients in Remission According to the Bardone-Cone Criteria
Status at last check: Not yet recruiting · NCT07924358
Anorexia Nervosa — Scales and questionnaires
ClinicalTrials.gov registration NCT07924358 · first posted Nov 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Status at last check: Not yet recruiting · NCT07923617
Conduct Disorder — Lidexamfetamine
ClinicalTrials.gov registration NCT07923617 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07923461 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07923032 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Status at last check: Not yet recruiting · NCT07922590
Alcohol Use Disorder (AUD), Suicide Ideation — Text Message (to remind of Integrated Plan content)
ClinicalTrials.gov registration NCT07922590 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Micronutrient Supplementation and Chronotherapy in Children With ADHD
Status at last check: Recruiting · NCT07922252
Attention Deficit Hyperactivity Disorder (ADHD) — Broad-spectrum multivitamin and mineral supplementation, Chronotherapy-Based Lifestyle Guidance
ClinicalTrials.gov registration NCT07922252 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07922239
Substance Use Behavior, Cannabis Intoxication, Alcohol Intoxication — Alcohol beverage, Cannabis (smoked flower), Simultaneous Alcohol and Cannabis
ClinicalTrials.gov registration NCT07922239 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Bioequivalence Study of Olanzapine Samidofen Tablets in Healthy Subjects Under Fasting Conditions.
Status at last check: Completed · NCT07922070
Bipolar I Disorder — Test Olanzapine Samidofen Tablets, reference (LYBALVI®) Olanzapine Samidofen Tablets
ClinicalTrials.gov registration NCT07922070 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
AI-assisted Home-based Intervention for ADHD Children
Status at last check: Recruiting · NCT07922018
ADHD - Attention Deficit Disorder With Hyperactivity, ADHD - Combined Type, ADHD - Inattentive Type — Generative artificial intelligence assisted diary platform home-based intervention, Consultations and psychoeducation on child emotional management
ClinicalTrials.gov registration NCT07922018 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07921966 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Status at last check: Not yet recruiting · NCT07921667
Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)
ClinicalTrials.gov registration NCT07921667 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07921654 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Status at last check: Not yet recruiting · NCT07921446
Adverse Childhood Experience, Depression / Major Depressive Disorder, Anxiety Depression, Anxiety — Lifestyle psychoeducation intervention, Personalized digital psychoeducation intervention on emotion regulation
ClinicalTrials.gov registration NCT07921446 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Concomitant Fibromyalgia and Psychiatric Disorders
Status at last check: Completed · NCT07920913
Fibromyalgia (FM), Depression
ClinicalTrials.gov registration NCT07920913 · first posted Nov 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07920601 · first posted Nov 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Affective Cognitive Training in Mood Disorders and High-risk Relatives
Status at last check: Recruiting · NCT07920302
Major Depressive Disorder (MDD), Bipolar Disorder (BD) — Targeted affective cognitive training
ClinicalTrials.gov registration NCT07920302 · first posted Nov 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Feasibility of a Web-based Single-session Intervention Combined With Ecological Momentary Assessment and Intervention for Patients With Complex Posttraumatic Stress Disorder Awaiting Inpatient Treatment
Status at last check: Not yet recruiting · NCT07920107
PTSD - Post Traumatic Stress Disorder, Depression, Anxiety, Complex Post-Traumatic Stress Disorder (CPTSD), Dissociation — Digital self-administered web-based single-session intervention, While Waiting application: Ecological momentary assessments and interventions
ClinicalTrials.gov registration NCT07920107 · first posted Nov 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07920081 · first posted Nov 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Alcohol Use, Cannabis Use, Health Literacy — Purple Town prevention program, Purple town mobile game
ClinicalTrials.gov registration NCT07919639 · first posted Nov 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Repetitive Transcranial Magnetic Stimulation Versus Theta Burst Stimulation on Impulsivity, Emotional Dysregulation, and Non-Suicidal Self-Injury in Borderline Personality Disorder Patients
ClinicalTrials.gov registration NCT07919587 · first posted Nov 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07919392 · first posted Nov 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Expressive Arts Therapy in Major Depression: An RCT
Status at last check: Not yet recruiting · NCT07919288
Depression - Major Depressive Disorder — Expressive Art Therapy, Usual Care
ClinicalTrials.gov registration NCT07919288 · first posted Nov 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07918222 · first posted Nov 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07917637 · first posted Nov 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Parent-Based Intervention for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID)
Status at last check: Not yet recruiting · NCT07916974
Anxiety Disorder of Adolescence, Avoidant / Restrictive Food Intake Disorder — Supportive Parenting for Anxious Childhood Emotions (SPACE), Nutritional Support (NS)
ClinicalTrials.gov registration NCT07916974 · first posted Nov 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Status at last check: Not yet recruiting · NCT07916792
Suicidal Ideas, Suicidal Ideation, Suicidal Thoughts, Firearm Safety — TEEN LENS, Usual Care
ClinicalTrials.gov registration NCT07916792 · first posted Nov 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Adapting the "Do More, Feel Better" Intervention for Older People Living With HIV
Status at last check: Not yet recruiting · NCT07915934
Depression, HIV — "Do More, Feel Better" for Older People with HIV
ClinicalTrials.gov registration NCT07915934 · first posted Nov 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07915427 · first posted Nov 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07914712 · first posted Nov 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07914634 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07913997 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Exploring The Effect of TikTok Trigger Warnings in a Clinical Sample of Youth at Risk of Suicide
Status at last check: Enrolling by invitation · NCT07913854
Suicide Prevention, Social Media Users — Trigger Warning
ClinicalTrials.gov registration NCT07913854 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
N-Acetylcysteine for Bipolar and Alcohol Use Disorders
Status at last check: Not yet recruiting · NCT07913542
Bipolar Disorder, Alcohol Use Disorder — N-acetyl cysteine, Placebo
ClinicalTrials.gov registration NCT07913542 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07913529 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07913503 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Examining the Effectiveness of a Brief Therapeutic Intervention for Reducing Self-Harm Among Adolescents
Status at last check: Not yet recruiting · NCT07913425
Self Injurious Behavior, Self Injurious Behavior Without Suicidal Intent — Cutting Down Program - a three-month cognitive-behavioral psychotherapy focused on reducing self-injury urges and behaviors in adolescents
ClinicalTrials.gov registration NCT07913425 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Real-World Impact of TV-44749 in Adults With Schizophrenia
Status at last check: Not yet recruiting · NCT07913100
Schizophrenia — TV-44749
ClinicalTrials.gov registration NCT07913100 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Family Accommodation Reduction in Adult Obsessive Compulsive Disorder
Status at last check: Enrolling by invitation · NCT07912177
Obsessive - Compulsive Disorder, Family Accommodation, OCD, CBT, Psychoeducation — Family Accommodation Reduction, Family Psychoeducation
ClinicalTrials.gov registration NCT07912177 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07911787 · first posted Nov 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Connecting Online Military Personnel to Alcohol Harm-reducing Smartphone Support Study
Status at last check: Not yet recruiting · NCT07911345
Alcohol Use Disorder (AUD) — VetChange (Explorer/Research version) Mobile App, Sober Time
ClinicalTrials.gov registration NCT07911345 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07911332
Pregnancy, Substance Use Disorder (SUD), Prisoners — Jail Diversion into Treatment, Referral at Release
ClinicalTrials.gov registration NCT07911332 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07910838 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
FLOW: Influence of the Menstrual Cycle on Alcohol Use in Women
Status at last check: Not yet recruiting · NCT07910643
Alcohol Use, Alcohol Consumption, Menstrual Cycle, Women's Health
ClinicalTrials.gov registration NCT07910643 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Immunobiological Mechanisms of Depression in Perimenopause
Status at last check: Recruiting · NCT07910552
Perimenopause, Major Depressive Episode (MDE)
ClinicalTrials.gov registration NCT07910552 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood Disorders
Status at last check: Not yet recruiting · NCT07910318
Major Depressive Disorder, Bipolar Disorder, Tobacco Use Disorder, Mood Disorders
ClinicalTrials.gov registration NCT07910318 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Neurobiological Markers of Non-suicidal Self-injury and Treatment Mechanisms of Adolescent Self-injury Intervention Skills Training
Status at last check: Recruiting · NCT07910110
Non-suicidal Self-injury (NSSI), Adolescent — Adolescent Self-Injury Intervention Skills Training (ASIST), Treatment as Usual (TAU)
ClinicalTrials.gov registration NCT07910110 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effects of Qigong Exercise on Anxiety and Depression in Patients Receiving Inpatient Treatment for Substance Use Disorder
Status at last check: Completed · NCT07909447
Substance Use Disorder (SUD), Anxiety, Depression — Qigong Exercises
ClinicalTrials.gov registration NCT07909447 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07909408
Early-stage Breast Cancer, Fear of Cancer Recurrence, Anxiety, Depression — Psilocybin 25 mg, Psilocybin 5 mg
ClinicalTrials.gov registration NCT07909408 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Temporal Interference Transcranial Alternating Current Stimulation Targeting the BNST or Amygdala for Generalized Anxiety Disorder
Status at last check: Recruiting · NCT07909200
Generalized Anxiety Disorder (GAD) — Temporal Interference transcranial Alternating Current Stimulation (TI-tACS), Temporal Interference transcranial Alternating Current Stimulation (TI-tACS), Sham Temporal Interference transcranial Alternating Current Stimulation (TI-tACS)
ClinicalTrials.gov registration NCT07909200 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia
Status at last check: Recruiting · NCT07908680
Schizophrenia — XEP527, Placebo
ClinicalTrials.gov registration NCT07908680 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effectiveness of Internet-based Unified Protocol (iUP) for Emotional Problems: A Randomized Controlled Trial
Status at last check: Not yet recruiting · NCT07908628
Depression - Major Depressive Disorder, Generalised Anxiety Disorder, Anxiety Disorder (Panic Disorder or GAD), Depressive and Anxiety Disorders — Internet-based Unified Protocol (iUP), Waitlist Control Group
ClinicalTrials.gov registration NCT07908628 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07908563 · first posted Nov 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Trauma-Related Attributions in Trauma Treatment: An Observational Study
Status at last check: Completed · NCT07908186
PTSD
ClinicalTrials.gov registration NCT07908186 · first posted Oct 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07907328
Binge-Eating Disorder — LIFU Neuromodulation
ClinicalTrials.gov registration NCT07907328 · first posted Oct 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Acceptance and Committment Therapy Combined With Ketamine in Difficult-to-Treat Depression.
Status at last check: Not yet recruiting · NCT07906496
Major Depressive Disorder (MDD) — K-ACT Intervention
ClinicalTrials.gov registration NCT07906496 · first posted Oct 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Hybrid Type 1 Randomized Controlled Trial of an Online and Text-Messaging Intervention to Prevent Alcohol and Cannabis Initiation, Escalation, and Consequences Among First-Year College Students
Status at last check: Not yet recruiting · NCT07905846
Alcohol, Cannabis — Online and Text Message Intervention
ClinicalTrials.gov registration NCT07905846 · first posted Oct 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Validation of Wearable Core Body Temperature-Based Circadian Rhythm Digital Biomarkers
Status at last check: Not yet recruiting · NCT07905378
Mood Disorders, Major Depressive Diorder, Bipolar Disorders, Mental Disorder
ClinicalTrials.gov registration NCT07905378 · first posted Oct 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Written Exposure Therapy Plus Adjunctive Methylphenidate Treatment for Veterans With PTSD
Status at last check: Not yet recruiting · NCT07904000
PTSD - Post Traumatic Stress Disorder — Written Exposure Therapy (WET), methylphenidate (MPH), placebo (PBO)
ClinicalTrials.gov registration NCT07904000 · first posted Oct 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use
Status at last check: Not yet recruiting · NCT07903974
Post Traumatic Stress Disorder PTSD, Hazardous Alcohol Use — Written Exposure Therapy (WET), Clinician Supported PTSD Coach App (CS-PTSD), Phone follow up
ClinicalTrials.gov registration NCT07903974 · first posted Oct 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
RISE for PTSD and Substance Use Disorder in Veterans
Status at last check: Not yet recruiting · NCT07903753
Stress Disorders, Post-Traumatic, Substance-Related Disorders — Written Exposure Therapy, Cognitive Behavioral Therapy for Substance Use Disorders (skill components), Cognitive Behavioral Therapy for Substance Use Disorders
ClinicalTrials.gov registration NCT07903753 · first posted Oct 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07903246 · first posted Oct 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Investigation of the Gut-Brain Axis in Alcohol Use Disorder
Status at last check: Not yet recruiting · NCT07902635
Alcohol Use Disorder (AUD), Alcohol Abstinence — Fecal Microbiota Transplantation (FMT) Procedure and Cognitive Behavioral Therapy (CBT) Procedure
ClinicalTrials.gov registration NCT07902635 · first posted Oct 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07902518 · first posted Oct 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Web-based Intervention Program for Postpartum Depression
Status at last check: Recruiting · NCT07902141
Postpartum Depression (PPD), Web-based Intervention — Web-based program for postpartum depression
ClinicalTrials.gov registration NCT07902141 · first posted Oct 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Friends/Family of Individuals at Risk of Suicide Training Program
Status at last check: Recruiting · NCT07902089
Caregiver, Caregiver Mental Health, Caregiver Stress, Suicide — FIRST Program
ClinicalTrials.gov registration NCT07902089 · first posted Oct 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
BEAR for Women Who Have Experienced Sexual Assault and Have Suicidal Thoughts
Status at last check: Not yet recruiting · NCT07902050
Sexual Assault and Rape, Suicidal Thoughts — BEAR Therapeutic Group
ClinicalTrials.gov registration NCT07902050 · first posted Oct 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
Status at last check: Recruiting · NCT07901179
Major Depressive Disorder (MDD) — ALKS 7290 Dose, Placebo
ClinicalTrials.gov registration NCT07901179 · first posted Oct 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07900893 · first posted Oct 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07900841
Post Traumatic Stress Disorder PTSD — Focused Ultrasound
ClinicalTrials.gov registration NCT07900841 · first posted Oct 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Peer-led, Mobile App Supported Linkage to Opioid Use Disorder Treatment
Status at last check: Not yet recruiting · NCT07900828
Opioid Use Disorder — Mobile phone-assisted intervention, Peer navigator, Standard of care referral for out-patient MAT
ClinicalTrials.gov registration NCT07900828 · first posted Oct 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Multimodal Biomarkers Predicting Medication-Induced Adverse Effects in Children With ADHD
Status at last check: Recruiting · NCT07900451
ADHD — methylphenidate
ClinicalTrials.gov registration NCT07900451 · first posted Oct 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Development and Evaluation of a Digital Game Intervention Targeting Children Vulnerable to ADHD
Status at last check: Not yet recruiting · NCT07900048
ADHD or ADHD Traits — Digital Game Intervention, Tetris
ClinicalTrials.gov registration NCT07900048 · first posted Oct 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07899424 · first posted Oct 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Integrated Psychoeducation Program for Internalized Stigma in Schizophrenia
Status at last check: Not yet recruiting · NCT07898852
Schizophrenia, Schizoaffective Disorder, Internalized Stigma, Social Stigma — Integrated Psychoeducation Program
ClinicalTrials.gov registration NCT07898852 · first posted Oct 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Reducing Stigma - A Treatment for Early Psychosis to Prevent Suicide
Status at last check: Not yet recruiting · NCT07898631
Suicide, Mental Health Stigma — RESTEPS
ClinicalTrials.gov registration NCT07898631 · first posted Oct 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
e-Perinatal Butterfly: An Embedded Study for Parents Experiencing Perinatal Loss
Status at last check: Not yet recruiting · NCT07898176
Depressive Symptoms, Perinatal Loss, Perinatal Grief, Anxiety Symptoms — e-Perinatal Butterfly, Standard routine maternal care
ClinicalTrials.gov registration NCT07898176 · first posted Oct 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluation of National Highly Specialized Care for Children and Adolescents With Severe Self-Harm or Eating Disorders
Status at last check: Recruiting · NCT07898059
Self-harm Behavior, Eating Disorders, Non-suicidal Self-injury (NSSI) — National Highly Specialized Care (NHV)
ClinicalTrials.gov registration NCT07898059 · first posted Oct 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07897266 · first posted Oct 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07896837 · first posted Oct 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Understanding the Neural Underpinnings of Risk-Taking Behavior in Psychiatric Disease
Status at last check: Recruiting · NCT07896343
Depression - Major Depressive Disorder — Approach-Avoidance Decision-Making Task
ClinicalTrials.gov registration NCT07896343 · first posted Oct 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Assessment of the Seasonality of Depressive Symptoms in Adolescents
Status at last check: Not yet recruiting · NCT07895758
Depressive Symptoms — Measuring the intensity of the seasonality of depressive symptoms in adolescents
ClinicalTrials.gov registration NCT07895758 · first posted Oct 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Linear Accelerator Radiosurgical Anterior Capsulotomy With Task-based fMRI Identification of PERSonalized and PrEdictiVE Biomarkers of REsponse in Treatment-Refractory Obsessive-Compulsive Disorder (PERSEVERE Trial)
Status at last check: Not yet recruiting · NCT07895706
ClinicalTrials.gov registration NCT07895706 · first posted Oct 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07895576 · first posted Oct 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07895134
Major Depression — Psilocybin, modafinil, zolpidem
ClinicalTrials.gov registration NCT07895134 · first posted Oct 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07894978
Body Image, Body Image Dissatisfaction, Eating Disorders, University Students, Prevention — Expand Your Horizon (EYH), Creative Writing Control
ClinicalTrials.gov registration NCT07894978 · first posted Oct 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Pain Sensitivity, Alcohol-Induced Analgesia, and Heavy Drinking in Individuals With Opioid Use Disorder
Status at last check: Not yet recruiting · NCT07894276
Opioid Use Disorder, Alcohol Intoxication, Pain — Alcohol, Placebo
ClinicalTrials.gov registration NCT07894276 · first posted Oct 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07894094
Attention-Deficit/Hyperactivity Disorder (ADHD)
ClinicalTrials.gov registration NCT07894094 · first posted Oct 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Acute Effects of a Single Dose of Ayahuasca on Cerebral Metabolism in Healthy Volunteers: a PET Study
Status at last check: Enrolling by invitation · NCT07893912
Healthy Adult Participants — Ayahuasca
ClinicalTrials.gov registration NCT07893912 · first posted Oct 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07893769 · first posted Oct 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Specialist Supportive Clinical Management (SSCM) for Children and Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa
Status at last check: Recruiting · NCT07893145
Anorexia Nervosa, Atypical Anorexia Nervosa — Specialist Supportive Clinical Management for Children and Adolescents (SSCM-Youth)
ClinicalTrials.gov registration NCT07893145 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Randomized, 52-Week Extension Study to Evaluate the Maintenance of Remission, Relapse Prevention, and Long-Term Safety of CreNeuroS™ in Patients With Major Depressive Disorder Who Achieved Remission Following an 8-Week Parent Study
Status at last check: Recruiting · NCT07893002
Adjunct in the Treatment of Depressive Disorder — No intervention, CreNeuroS™ CNS Fish Oil Plus Softgels, 1 capsule orally once daily, CreNeuroS™ CNS Fish Oil Plus Softgels, 2 capsule orally once daily
ClinicalTrials.gov registration NCT07893002 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Clinical Trial to Evaluate the Efficacy and Safety of Meltz, a Digital Therapeutic Device, for Improving Panic Symptoms in Patients With Panic Disorder
Status at last check: Not yet recruiting · NCT07892885
ClinicalTrials.gov registration NCT07892885 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07892768 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07892287
Depression - Major Depressive Disorder — Repetitive Transcranial Magnetic Stimulation, Alpha-down EEG Neurofeedback
ClinicalTrials.gov registration NCT07892287 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
REM Sleep Disruption and Its Potential Uses in Depression Management
Status at last check: Completed · NCT07891806
Depression / Major Depressive Disorder, Depressed Mood — REM-Contingent Smartwatch Haptic Stimulation, Smartwatch Sleep Monitoring and Smart Alarm
ClinicalTrials.gov registration NCT07891806 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effects of a School-Based Trauma-Informed Psychosocial Competence Intervention on Nonsuicidal Self-Injury in Adolescents
Status at last check: Not yet recruiting · NCT07891754
Nonsuicidal Self-Injury — Trauma-Informed Psychosocial Competence (TIPC) Program
ClinicalTrials.gov registration NCT07891754 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Neural Mechanisms of Real-world Emotions and Internalizing
Status at last check: Recruiting · NCT07891624
Major Depression, Generalized Anxiety, Emotions — Academic Performance Feedback
ClinicalTrials.gov registration NCT07891624 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Posttraumatic Stress Disorder (PTSD) — Web-based Think/No-Think retrieval-suppression training
ClinicalTrials.gov registration NCT07891559 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Pilot Study of a Behavioral Program for Depression in Skilled Nursing Facility Residents and Care Partners
Status at last check: Completed · NCT07891546
Nursing Home Resident, Skilled Nursing Facility, Depression, Feasibility Studies, Caregiver — Interventions for Stressful Transitions in Later Life (InSTILL)
ClinicalTrials.gov registration NCT07891546 · first posted Oct 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07890896 · first posted Oct 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluating the PolarUs App in People With Bipolar Disorder
Status at last check: Not yet recruiting · NCT07890805
Bipolar Disorder (BD), Quality of Life (QOL) — PolarUs Mobile App
ClinicalTrials.gov registration NCT07890805 · first posted Oct 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Testing a Non-Deceptive Placebo Intervention for Subclinical Depressive Symptoms
Status at last check: Not yet recruiting · NCT07889908
Depression - Major Depressive Disorder, Psychological Distress, Depression / Major Depressive Disorder — Non-deceptive placebo (NDP)
ClinicalTrials.gov registration NCT07889908 · first posted Oct 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
MDD, Severe Depression, Major Depressive Episode — Transcranial Magnetic Stimulation (TMS)
ClinicalTrials.gov registration NCT07889739 · first posted Oct 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07888933 · first posted Oct 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders
Status at last check: Not yet recruiting · NCT07888894
Psychoses, Metabolic Syndrome — Targeted Health Dialogues
ClinicalTrials.gov registration NCT07888894 · first posted Oct 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07888387 · first posted Oct 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Dialectical Behavior Therapy for Adolescent With Repeated Suicidal and Self-harming Behavior in Tanta University Hospitals
Status at last check: Completed · NCT07888270
Dialectical Behavior Therapy, Suicidal, Adolescent, Behavior — Dialectical Behavior Therapy, Individual and Group Supportive Therapy group
ClinicalTrials.gov registration NCT07888270 · first posted Oct 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07887997 · first posted Oct 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07887633 · first posted Oct 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07887178 · first posted Oct 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07886840 · first posted Oct 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07886606 · first posted Oct 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluation of a Multi-Layered Digital Phenotyping, Digital Safety Plan, and Pharmacogenomic Intervention for Suicide Prevention in Adults With Depression
Status at last check: Recruiting · NCT07885722
Depressive Disorder, Major Depressive Disorder, Suicidal Ideation, Suicide, Attempted, Suicide Prevention — Digital Monitoring (Active/Passive EMA), Ecological Momentary Intervention (EMI) via Digital Safety Plan, Pharmacogenetic-Guided Care and Therapeutic Drug Monitoring
ClinicalTrials.gov registration NCT07885722 · first posted Oct 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A School-Based Intervention to Prevent Disordered Eating in Middle School Students
Status at last check: Completed · NCT07885631
Disordered Eating Behaviors — School-Based Disordered Eating Prevention Education Program
ClinicalTrials.gov registration NCT07885631 · first posted Oct 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Cognitive Behavioral Therapy for Substance Use and Mental Health in University Students
Status at last check: Completed · NCT07884422
Substance Use Behavior — Cognitive-Behavioral Therapy (CBT)-Based Group Intervention, Group Counseling Program
ClinicalTrials.gov registration NCT07884422 · first posted Oct 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Developing Virtual Reality Programs to Address Social Skills Deficits in Youth With ADHD
Status at last check: Not yet recruiting · NCT07882823
Attention-Deficit/Hyperactivity Disorder (ADHD) — VIP Suite
ClinicalTrials.gov registration NCT07882823 · first posted Oct 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
Status at last check: Recruiting · NCT07881016
Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP), Bipolar Disorder (BD), Major Depressive Disorder (MDD, Treatment-resistant Depression (TRD), Autism Spectrum Disorder (ASD — 3T Brain MRI, Biological Sampling, Clinical, Cognitive and Digital Assessments
ClinicalTrials.gov registration NCT07881016 · first posted Oct 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07880652 · first posted Oct 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07880457 · first posted Oct 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07880340
Post Traumatic Stress Disorder PTSD, Suicidal Ideation — Deep Transcranial Magnetic Stimulation (DTMS)
ClinicalTrials.gov registration NCT07880340 · first posted Oct 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Test of Acceptance-based Bibliotherapy for Hoarding Disorder
Status at last check: Not yet recruiting · NCT07880236
Hoarding Disorder — Acceptance and Commitment Therapy Bibliotherapy
ClinicalTrials.gov registration NCT07880236 · first posted Oct 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07880028 · first posted Oct 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Digital Phenotypes for Predicting Depression_Validation
Status at last check: Enrolling by invitation · NCT07880015
Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder, Mood Disorders
ClinicalTrials.gov registration NCT07880015 · first posted Oct 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Dual Neuromodulation for Depression: Boosting TMS With tES
Status at last check: Not yet recruiting · NCT07879924
Depression - Major Depressive Disorder — Transcranial Magnetic Stimulation, Transcranial Alternating Current Stimulation
ClinicalTrials.gov registration NCT07879924 · first posted Oct 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Semaglutide for the Treatment of Cannabis Use Disorder
Status at last check: Not yet recruiting · NCT07879612
Cannabis Use Disorder, Cue-reactivity — semaglutide
ClinicalTrials.gov registration NCT07879612 · first posted Oct 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental Illness
Status at last check: Not yet recruiting · NCT07879131
Severe Mental Illness, Bipolar Disorder, Schizophrenia, Schizoaffective Disorder, Major Depressive Disorder — MoodSync, Standard care
ClinicalTrials.gov registration NCT07879131 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental Illness
Status at last check: Not yet recruiting · NCT07879118
Schizophenia Disorder, Severe Mental Illness, Bipolar Disorder, Nonorganic Psychosis, Schizo-affective Disorder — Occupational Therapy Group Intervention
ClinicalTrials.gov registration NCT07879118 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluation of National Highly Specialized Care for Adults With Treatment-Resistant Self-Harm and Eating Disorders: Substudy 1
Status at last check: Recruiting · NCT07878897
Self-harm Behavior, Eating Disorders, Non-suicidal Self-injury (NSSI) — National Highly Specialized Care (NHV)
ClinicalTrials.gov registration NCT07878897 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Remote Medical Monitoring of Patients With Depression
Status at last check: Recruiting · NCT07878754
Depression Chronic, Depression and Quality of Life, Depression, Major Depressive Episode — Use of ThIA Medical Device
ClinicalTrials.gov registration NCT07878754 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07878624 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
An Investigation of Mechanisms That Underly Paranoia in Behaviour and Brain That Can Inform Clinical Diagnoses That Include Paranoid Symptoms.
Status at last check: Not yet recruiting · NCT07878130
None Volunteer — Low-dose THC administration via IV, High-Dose THC administration via IV, Saline administration via IV
ClinicalTrials.gov registration NCT07878130 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07877987 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07877675 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effectiveness of Health Communication on Depression Elderly in Ho Chi Minh City
Status at last check: Recruiting · NCT07877571
Depression - Major Depressive Disorder — Health Communication, Health communication
ClinicalTrials.gov registration NCT07877571 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07877402
Depression — Outdoor, Indoor
ClinicalTrials.gov registration NCT07877402 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Artificial Intelligence-Powered Virtual Reality Exposure Therapy for OCD in College Students: A Proof-of-Concept Study
Status at last check: Not yet recruiting · NCT07877363
Obsessive Compulsive Disorder (OCD) — Traditional Exposure and Response Prevention (ERP), Artificial Intelligence-Powered Virtual Reality Exposure Therapy (AI-VRET)
ClinicalTrials.gov registration NCT07877363 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07877207 · first posted Oct 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
SAINT® Therapy for Memory Problems in Older Adults With Treatment-Resistant Depression
Status at last check: Recruiting · NCT07876908
Depressive Disorder, Treatment-Resistant, Memory Deficits — Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®) with the Magnus Neuromodulation System
ClinicalTrials.gov registration NCT07876908 · first posted Oct 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Feasibility and Preliminary Outcomes of Compassion-Focused Group Therapy for Depression and Anxiety
Status at last check: Completed · NCT07876453
Depression / Major Depressive Disorder, Anxiety Disorder (Panic Disorder or GAD) — Compassion-Focused Group Therapy (CFT)
ClinicalTrials.gov registration NCT07876453 · first posted Oct 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Validation and Comparative Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early Detection of Schizophrenia
Status at last check: Active, not recruiting · NCT07876089
Schizophrenia / Schizoaffective Disorder
ClinicalTrials.gov registration NCT07876089 · first posted Oct 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07875790 · first posted Oct 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07875361
Substance Use Disorder (SUD), Opioid Use Disorder, Alcohol Use Disorder (AUD), Drug Use, Overdose
ClinicalTrials.gov registration NCT07875361 · first posted Oct 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
An Online Tailored Cognitive Therapy-Based Intervention for Depression in Multiple Sclerosis: ACTION-MS Online
Status at last check: Not yet recruiting · NCT07875309
Depression and Anxiety Symptoms, Multiple Sclerosis — ACTION-MS website - an 8-week cognitive behavioural therapy intervention for depression., The 'Health and Wellbeing in MS' website
ClinicalTrials.gov registration NCT07875309 · first posted Oct 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07875166 · first posted Oct 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07874620 · first posted Oct 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Recovery Management Checkup Scalability and Sustainability Hybrid Experiment
Status at last check: Not yet recruiting · NCT07873944
Substance Use Disorder (SUD), Opioid Use Disorders, Stimulant Overdose, Overdose Risk, Alcohol Use Disorder — Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters), Recovery Management Checkups (RMC) delivered by staff under the research team…
ClinicalTrials.gov registration NCT07873944 · first posted Oct 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Digital Single-Session Cognitive Behavioural Therapy in Healthy Adults
Status at last check: Completed · NCT07873905
Depression / Major Depressive Disorder, Anxiety, Anxiety Disorder Generalized — Digital single-session cognitive behavioural therapy, Digital memory task
ClinicalTrials.gov registration NCT07873905 · first posted Oct 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07873684 · first posted Oct 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07873060 · first posted Oct 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07872917 · first posted Oct 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum Disorder
Status at last check: Not yet recruiting · NCT07872878
Bipolar Disorder (BD) — Structured clinical follow-up and psychometric assessment, Structured clinical follow-up and psychometric assessment
ClinicalTrials.gov registration NCT07872878 · first posted Oct 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07872761 · first posted Oct 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Study is Investigating the Effectiveness of the Traditional Islamically Integrated Psychotherapy Using the Islamic Workbook for Religious Obsessive-Compulsive Disorder in Turkish Adults Who Suffer From Scrupulosity
ClinicalTrials.gov registration NCT07872462 · first posted Oct 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder
Status at last check: Not yet recruiting · NCT07871877
Opioid Use Disorder, Opioid Withdrawal, Substance Use Disorders — Ibogaine Hydrochloride, Extended-release naltrexone injection, 380 mg, Matching Oral Placebo
ClinicalTrials.gov registration NCT07871877 · first posted Oct 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07871344
Obsessive-Compulsive Disorder (OCD) — Mindfulness-based cognitive-behavioral therapy digital program
ClinicalTrials.gov registration NCT07871344 · first posted Oct 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07870187 · first posted Oct 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07869810 · first posted Oct 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07868913 · first posted Oct 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07868627 · first posted Oct 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07868536 · first posted Oct 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
PREWELL Digital Well-being Promotion Intervention With the BitHabit App
Status at last check: Active, not recruiting · NCT07868146
General Mental Health and Well-Being, Mental Disorders, Common Mental Disorders (CMD) — Digital wellbeing promoting intervention with the BitHabit app
ClinicalTrials.gov registration NCT07868146 · first posted Oct 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Self-administered Neurostimulation Intervention for Firefighter Traumatic Stress to Reduce Alcohol Use: Pilot Study
Status at last check: Not yet recruiting · NCT07868055
Posttraumatic Stress Symptoms, Heavy Alcoholic Consumption, Alcohol Use Disorder (AUD) — Transcutaneous auricular neurostimulation (tAN), Active Sham
ClinicalTrials.gov registration NCT07868055 · first posted Oct 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Feasibility Trial of a Parent Peer-Co-Led Caregiver Group for Pediatric Early Onset Schizophrenia Spectrum Disorders
Status at last check: Not yet recruiting · NCT07867964
Schizophrenia; Psychosis — Group Therapy, Treatment as Usual (TAU)
ClinicalTrials.gov registration NCT07867964 · first posted Oct 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Dysfunction of Respiratory Enzymes in Adults With Mental Illness (DREAM)
Status at last check: Completed · NCT07866833
Schizophrenia and Other Psychotic Disorders, Healthy Adult — Methylene Blue
ClinicalTrials.gov registration NCT07866833 · first posted Oct 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty Versus Applied Relaxation
Status at last check: Not yet recruiting · NCT07866794
Mental Disorders, Mood Disorders, Anxiety Disorders, Generalized Anxiety Disorder — Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty (CBT-IU), Group Transdiagnostic Applied Relaxation (AR)
ClinicalTrials.gov registration NCT07866794 · first posted Oct 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07866079 · first posted Oct 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
AI-Enabled Wearable Monitoring for Detection of Postpartum Depression and Anxiety
Status at last check: Not yet recruiting · NCT07866053
Postpartum Depression (PPD), Postpartum Anxiety
ClinicalTrials.gov registration NCT07866053 · first posted Oct 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Transdiagnostic Sleep Intervention to Improve Mental Health in Adolescents
Status at last check: Not yet recruiting · NCT07865728
Sleep Disturbance, Sleep Problems, Substance Use (Drugs, Alcohol), Anxiety, Depression — Transdiagnostic Intervention for Sleep and Circadian Dysfunction, Healthy habits psychoeducation
ClinicalTrials.gov registration NCT07865728 · first posted Oct 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07864961 · first posted Oct 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07864675
Obsessive Compulsive Behavior — Digital behavioral training
ClinicalTrials.gov registration NCT07864675 · first posted Oct 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07864324 · first posted Oct 7, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
An Interrupted Time-Series Pilot Trial of LGBTQ-Affirming Cognitive Processing Therapy for Interpersonal and Developmental Trauma
Status at last check: Not yet recruiting · NCT07863817
Post-Traumatic Stress Disorder, Chronic, Depressed Mood, Depressive and Anxiety Disorders, Anxiety, Depression - Major Depressive Disorder — Cognitive Processing Therapy
ClinicalTrials.gov registration NCT07863817 · first posted Oct 7, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Digital Cognitive Behavioral Therapy for Gambling Disorder
Status at last check: Recruiting · NCT07863440
Gambling Disorder, Gambling — Digital Cognitive Behavioral Therapy for Gambling Disorder, Digital Family Intervention for Gambling-Related Harms, Face-to-Face Cognitive Behavioral Therapy for Gambling Disorder
ClinicalTrials.gov registration NCT07863440 · first posted Oct 7, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effects of HIIT and Dual-Task Training in Children With ADHD
Status at last check: Completed · NCT07863362
Attention-Deficit/Hyperactivity Disorder (ADHD), Physiotherapy — High-Intensity Interval Training With Dual-Task Training
ClinicalTrials.gov registration NCT07863362 · first posted Oct 7, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07863089 · first posted Oct 7, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07862803 · first posted Oct 7, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07862712 · first posted Oct 7, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression
Status at last check: Recruiting · NCT07862205
Major Depressive Disorder (MDD), Treatment Resistant Depression, Major Depression — MagVenture TMS Therapy System with Localite Navigation System and actiCHamp EEG
ClinicalTrials.gov registration NCT07862205 · first posted Oct 7, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07861919 · first posted Oct 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07860957 · first posted Oct 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07860320 · first posted Oct 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
TMS + Exposure Therapy for Pediatric OCD: Second Phase
Status at last check: Recruiting · NCT07859683
Obsessive Compulsive Behavior — Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area, Transcranial Magnetic Stimulation: Sham, Exposure with Response Prevention
ClinicalTrials.gov registration NCT07859683 · first posted Oct 6, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder
ClinicalTrials.gov registration NCT07858565 · first posted Oct 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluation of Effectiveness of the LifeSkills Training - Lombardia - Primary Shool Program ( Val3P-LST )
Status at last check: Active, not recruiting · NCT07858513
Well Being, Drug Addiction, Tobacco Use, Alcohol Abuse, Life Skills, Violence, Bullying, Health Literacy — life skills primary prevention
ClinicalTrials.gov registration NCT07858513 · first posted Oct 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Cardiovascular Safety of Atomoxetine in Children With ADHD
Status at last check: Not yet recruiting · NCT07858448
Attention Deficit Hyperactivity Disorder
ClinicalTrials.gov registration NCT07858448 · first posted Oct 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07857629 · first posted Oct 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Clinical Protocol for VR-Assisted CBT Targeting Quality of Life Outcomes for OCD
Status at last check: Active, not recruiting · NCT07857577
OCD — VR-CBT, G-VRET
ClinicalTrials.gov registration NCT07857577 · first posted Oct 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07857291 · first posted Oct 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Seasonality, Chronotype, Impulsivity, and Suicidality in Mood Disorder Patients
Status at last check: Completed · NCT07857213
Bipolar Disorder in Remission, Major Depression in Remission
ClinicalTrials.gov registration NCT07857213 · first posted Oct 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluating the Therapeutic Potential of Focal Electrically Administered Seizure Therapy (FEAST) in the Treatment of Depression: A Multicenter Randomized Clinical Trial
Status at last check: Not yet recruiting · NCT07857122
Major Depressive Episode (MDE), Unipolar Disorder, Bipolar 1 Disorder — Stimulation by the Sigma ECT/FEAST device, Stimulation by Sigmastim ECT 200J device administered in right unilateral (RUL), Stimulation by Sigmastim ECT 200J device administered in bilateral (BT)
ClinicalTrials.gov registration NCT07857122 · first posted Oct 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Cognitive and Behavioral Approaches to Reduce Binge Eating and Excess Weight in Adolescents (Online)
Status at last check: Not yet recruiting · NCT07856784
Binge Eating, Overweight and Obesity, Eating Disorders in Adolescence — Cognitive-Behavioral Therapy for Adolescent Binge Eating, Lifestyle Behavioral Obesity Intervention, Active Control
ClinicalTrials.gov registration NCT07856784 · first posted Oct 5, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment
ClinicalTrials.gov registration NCT07856420 · first posted Oct 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Understanding Lifespan Trajectories of Social Cognition, Brain Microstructure and Iron Dysregulation in Schizophrenia
Status at last check: Recruiting · NCT07856381
Healthy Control Subjects, Schizophrenia Diagnosis
ClinicalTrials.gov registration NCT07856381 · first posted Oct 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Neuronavigated rTMS for Treatment-Resistant Auditory Hallucinations
Status at last check: Recruiting · NCT07856368
Schizophrenia, Auditory Verbal Hallucinations — Neuronavigated repetitive transcranial magnetic stimulation (rTMS), Sham repetitive transcranial magnetic stimulation (rTMS)
ClinicalTrials.gov registration NCT07856368 · first posted Oct 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Is Craving a Central Criterion for Diagnosing a Behavioral Addiction?
Status at last check: Recruiting · NCT07854912
Addictive Behaviors, Internet Addiction Disorder, Gambling, Technology Addiction, Food Addiction, Compulsive Sexual Behavior, Screen Use — Questionnaires, Telephone interview
ClinicalTrials.gov registration NCT07854912 · first posted Oct 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effect of TMS Treatment on Defense Mechanisms and Functionality in Patients With Depression
Status at last check: Not yet recruiting · NCT07853989
Major Depressive Disorder (MDD)
ClinicalTrials.gov registration NCT07853989 · first posted Oct 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07853807 · first posted Oct 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Predictors of Treatment Outcome in Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07853365
Major Depressive Disorder
ClinicalTrials.gov registration NCT07853365 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Brave Heart Intervention and Mental Health Outcomes Among Young People in Sierra Leone
Status at last check: Completed · NCT07853092
Substance-related Disorders, Mental Health Literacy, Adolescent Health, Substance Use Disorder (SUD) — Brave Heart Intervention
ClinicalTrials.gov registration NCT07853092 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Motivational Intervention for Patients With Schizophrenia
Status at last check: Not yet recruiting · NCT07853079
Schizo-affective Disorder, Non Organic Psychosis, Schizophenia Disorder — Positive Emotion Program for Schizophrenia (PEPS), a psychotherapeutic intervention,
ClinicalTrials.gov registration NCT07853079 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Examination of Transcranial Focused Ultrasound on Brain Activity in Adults With Cocaine Use Disorder
Status at last check: Not yet recruiting · NCT07852923
Cocaine Use Disorder (CUD) — tFUS, Sham tFUS
ClinicalTrials.gov registration NCT07852923 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effects of Psilocybin on Craving in Nicotine Dependence
Status at last check: Not yet recruiting · NCT07852832
Nicotine Dependence — Psilocybin (drug)
ClinicalTrials.gov registration NCT07852832 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
HBOT Effects on First Responders' Cognition and Well-Being
Status at last check: Recruiting · NCT07852728
Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Anxiety, Depression, Post Concussion Symptoms — Hyperbaric Oxygen Therapy (HBOT)
ClinicalTrials.gov registration NCT07852728 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Pilot Study of a DBT-Informed Caregiver Risk Management Workshop
Status at last check: Not yet recruiting · NCT07852429
Caregivers, Suicide, Nonsuicidal Self Injury, Adolescent, Young Adult — Workshop and consultation for caregivers of at risk youth
ClinicalTrials.gov registration NCT07852429 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
iTBS Versus Standard 10 Hz rTMS for Treatment-Resistant Depression (TRD)
Status at last check: Active, not recruiting · NCT07852065
Major Depression — iTBS, rTMS
ClinicalTrials.gov registration NCT07852065 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Sleep Architecture, Cognitive Function, and Quality of Life During Early Recovery From Substance Use Disorder
Status at last check: Not yet recruiting · NCT07852052
Substance-Related Disorders, Substance Use Disorder, Sleep Wake Disorders, Cognitive Dysfunction
ClinicalTrials.gov registration NCT07852052 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Validation of an Algorithm for Predicting Awakenings Associated With Trauma-related Nightmares, Based on the Analysis of Physiological Patterns in Military and Former Military Patients Suffering From Post-traumatic Stress Disorder
ClinicalTrials.gov registration NCT07851480 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Anger, Social Cognition and Post-traumatic Stress Disorder in Former French Military Personnel
Status at last check: Recruiting · NCT07851090
Post Traumatic Stress Disorder
ClinicalTrials.gov registration NCT07851090 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07851038 · first posted Oct 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Assessment of the Preventive Effect of Defusing on Traumatic Kindling
Status at last check: Not yet recruiting · NCT07850193
Acute Stress Disorder, Post Traumatic Stress Disorder PTSD — Defusing, Psychological First Aid (PFA)
ClinicalTrials.gov registration NCT07850193 · first posted Sep 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07850102
SCHIZOPHRENIA 1 (Disorder) — DSP-2342
ClinicalTrials.gov registration NCT07850102 · first posted Sep 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Anhedonia Beyond Depressive Symptoms in Children and Adolescents With Conduct Disorder
Status at last check: Not yet recruiting · NCT07849985
Conduct Disorder, Depression
ClinicalTrials.gov registration NCT07849985 · first posted Sep 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder During Pregnancy
Status at last check: Not yet recruiting · NCT07849530
Methamphetamine Use Disorder, Pregnancy — 4- Week Dual-Target Transcranial Magnetic Stimulation (TMS), Accelerated Dual-Target Transcranial Magnetic Stimulation (aTMS), Treatment as Usual (TAU)
ClinicalTrials.gov registration NCT07849530 · first posted Sep 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07849465 · first posted Sep 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07848620 · first posted Sep 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07848477 · first posted Sep 30, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07847242 · first posted Sep 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluation of a Brief, Scalable Module to Mitigate Suicidal Ideation Among Youth (Phase 2)
Status at last check: Not yet recruiting · NCT07847008
Perceived Burdensomeness, Suicidal Ideation — Safety Planning, Give to Others (GO) Module, MATCH (Modular Approach to Therapy for Children) - Anxiety and Depression Modules
ClinicalTrials.gov registration NCT07847008 · first posted Sep 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07846735
Substance Abuse, Opioid Abuse (Disorder), Overdose Prevention, Substance Use Disorder (SUD), Adolescent Substance Use, Rural Health — Navigator - Flexible Care Management
ClinicalTrials.gov registration NCT07846735 · first posted Sep 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07846072 · first posted Sep 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Multi-Component Training Versus Motor Learning Techniques in Adults With ADHD
Status at last check: Not yet recruiting · NCT07845981
Attention Deficit Hyperactivity Disorder — Multi-Component Training, Motor Learning Techniques
ClinicalTrials.gov registration NCT07845981 · first posted Sep 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Major Depressive Disorder (MDD) — Adalimumab Biosimilars Injection, Placebo
ClinicalTrials.gov registration NCT07845604 · first posted Sep 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07845461 · first posted Sep 29, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar Disorders
Status at last check: Not yet recruiting · NCT07845409
Bipolar Disorder, Bipolar and Related Disorders, Veterans, Suicide, Suicidal Ideation, Mental Disorders — Soterix 1x1 tES mini-CT
ClinicalTrials.gov registration NCT07845409 · first posted Sep 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Methodology of Super-Early Training of Developer Engineers and Leading Analysts With a Diagnosis of ADHD/ASD for Ensuring the Engineering Sovereignty of the State: Time Horizon: 2026-2038-2050
Status at last check: Active, not recruiting · NCT07845292
Attention Deficit Hyperactivity Disorder (ADHD) — Voice of Sleep "MamaBee" training modules (Fairy Tales)
ClinicalTrials.gov registration NCT07845292 · first posted Sep 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07844733 · first posted Sep 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder
Status at last check: Recruiting · NCT07844720
Alcohol Use Disorder — Thiamine
ClinicalTrials.gov registration NCT07844720 · first posted Sep 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07843927 · first posted Sep 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07843875 · first posted Sep 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07843654 · first posted Sep 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07843056 · first posted Sep 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation
Status at last check: Recruiting · NCT07842601
Opioid Use Disorder, Major Depressive Disorder (MDD) — Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS)
ClinicalTrials.gov registration NCT07842601 · first posted Sep 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic Decision-Making.
Status at last check: Not yet recruiting · NCT07842588
Alcohol Use Disorder (AUD), Suicidal Ideation — CBT4CBT
ClinicalTrials.gov registration NCT07842588 · first posted Sep 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07841483 · first posted Sep 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07841418 · first posted Sep 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Deep Brain Reorienting for Posttraumatic Stress Disorder
Status at last check: Recruiting · NCT07840417
Posttraumatic Stress Disorder (PTSD), Posttraumatic Stress Symptom — Deep Brain Reorienting, Treatment as Usual (TAU)
ClinicalTrials.gov registration NCT07840417 · first posted Sep 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07840079 · first posted Sep 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study Comparing Oral Ketamine With Oral Midazolam for the Treatment of Major Depressive Episodes
Status at last check: Not yet recruiting · NCT07839338
Major Depressive Episode — Oral ketamine, Oral midazolam
ClinicalTrials.gov registration NCT07839338 · first posted Sep 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Measurement-Based Care to Support Buprenorphine-Naloxone Treatment in Outpatient Addiction Clinics
Status at last check: Not yet recruiting · NCT07839182
Opioid Use Disorder — Bup-MBC
ClinicalTrials.gov registration NCT07839182 · first posted Sep 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Suicide Ideation — Psychological Capital (PsyCap) Development Intervention
ClinicalTrials.gov registration NCT07839117 · first posted Sep 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Brain Function and Cognitive Control Training in Children With Obsessive-Compulsive Symptoms
Status at last check: Not yet recruiting · NCT07839013
Obsessive-Compulsive Symptoms, Cognitive Control — Cognitive Control Training
ClinicalTrials.gov registration NCT07839013 · first posted Sep 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder
Status at last check: Not yet recruiting · NCT07838311
ADHD, Cannabis Use Disorder — Delayed-release, extended-release methylphenidate, Placebo
ClinicalTrials.gov registration NCT07838311 · first posted Sep 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Implementing BEAM: A Scalable Digital Mental Health Program, for Families of Children Referred to Neurodevelopmental Services
Status at last check: Not yet recruiting · NCT07837791
Depression and Anxiety Symptom, Anger, Parenting, Stress (Psychology), Parent Child Relationship, Child Development, Neurodevelopmental Conditions — The Building Emotional Awareness and Mental Health (BEAM) Program
ClinicalTrials.gov registration NCT07837791 · first posted Sep 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Psychological Resilience and Quality of Life Among Caregivers of Patients With Schizophrenia
Status at last check: Not yet recruiting · NCT07837479
Schizophrenia, Caregiver Burden, Quality of Life
ClinicalTrials.gov registration NCT07837479 · first posted Sep 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Novel Approaches to Supporting Students With ADHD in Multi-Tiered Systems of Support
Status at last check: Not yet recruiting · NCT07836972
Attention Deficit Hyerpactivity Disorder — Academic Competency Enhancement (ACE) classroom, School as Usual Classroom Supports
ClinicalTrials.gov registration NCT07836972 · first posted Sep 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
Status at last check: Recruiting · NCT07836647
Post Traumatic Stress Disorder — TSND-201, Placebo
ClinicalTrials.gov registration NCT07836647 · first posted Sep 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Physical Activity for Depressive Symptoms in Adults With Obesity: A Randomized Controlled Feasibility Trial
Status at last check: Not yet recruiting · NCT07836582
Obesity & Overweight, Depression Disorders — Supervised Physical Activity Program
ClinicalTrials.gov registration NCT07836582 · first posted Sep 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward
Status at last check: Recruiting · NCT07836348
Psychotic Disorders — Inpatient Care in a Closed Unit Incorporating Soteria Elements, Conventional Closed Psychiatric Inpatient Care
ClinicalTrials.gov registration NCT07836348 · first posted Sep 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI
Status at last check: Completed · NCT07836244
White Matter Abnormalities, Nonspecific, ADHD, Neurodevelopment Outcome
ClinicalTrials.gov registration NCT07836244 · first posted Sep 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Thrive at Home: A Virtual Reality Social Intervention for Older Adults
Status at last check: Not yet recruiting · NCT07835568
Mental Health (Depression), Mental Health and General Well-being, Loneliness, Well Being, Caregiver Burden, Caregiver Wellbeing, Mild Cognitive Impairment(MCI), Alzheimer Dementia (AD), Dementia — Full Virtual Reality Social Intervention, Abbreviated Virtual Reality Social…
ClinicalTrials.gov registration NCT07835568 · first posted Sep 23, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Home-Based Randomized Trial of Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression
Status at last check: Not yet recruiting · NCT07834762
Treatment Resistant Depression (TRD), Major Depressive Disorder (MDD) — Spaced Transcranial Direct Current Stimulation (tDCS), Sham Spaced tDCS
ClinicalTrials.gov registration NCT07834762 · first posted Sep 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07834684 · first posted Sep 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07834606 · first posted Sep 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Clinical and Biological Correlates of Obsessive-Compulsive Disorder and Online Mindfulness-Based Cognitive Therapy
Status at last check: Recruiting · NCT07834567
Obsessive - Compulsive Disorder — Mindfulness-based Cognitive Therapy for OCD
ClinicalTrials.gov registration NCT07834567 · first posted Sep 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Comparison of Group Cognitive Behavioural Therapy (CBT) and Structured Activity Group for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status at last check: Recruiting · NCT07834437
ADHD — Group CBT based on DBT-skills training, Activity group
ClinicalTrials.gov registration NCT07834437 · first posted Sep 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Early Psychosis, Psychosis, Schizophrenia, Bipolar Disorder With Psychosis, Schizoaffective Disorder
ClinicalTrials.gov registration NCT07834203 · first posted Sep 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder
Status at last check: Completed · NCT07834112
Bipolar Disorder (BD) — Lurasidone
ClinicalTrials.gov registration NCT07834112 · first posted Sep 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07833761 · first posted Sep 22, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07831135 · first posted Sep 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Physiopathology of Behavioral Addictions and Biomarkers
Status at last check: Not yet recruiting · NCT07830680
Food Addiction, Sexual Addiction — blood sampling
ClinicalTrials.gov registration NCT07830680 · first posted Sep 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Amygdala-Targeted Transcranial Temporal Interference Stimulation for Major Depressive Disorder: A Randomized Sham-Controlled Trial of Clinical Efficacy and Neurobiological Mechanisms
Status at last check: Not yet recruiting · NCT07829575
ClinicalTrials.gov registration NCT07829575 · first posted Sep 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07829510
Post-Traumatic Stress Disorder (PTSD), Depression, Substance Use Disorder, Traumatic Injury — Trauma Resilience and Recovery Program Portal 2.0 (TRRP 2.0)
ClinicalTrials.gov registration NCT07829510 · first posted Sep 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Open-label Feasibility Trial of HD-tDCS During Cognitive Behavioral Therapy for Cocaine Use Disorder
Status at last check: Recruiting · NCT07829263
Cocaine Use Disorder — High Definition Transcranial Direct Current Stimulation
ClinicalTrials.gov registration NCT07829263 · first posted Sep 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Development of Low-Intensity Focused Ultrasound for Post Traumatic Brain Injury Depression
Status at last check: Not yet recruiting · NCT07828483
Post-traumatic Brain Injury Depression, Veteran Health — Active Low-Intensity Focused Ultrasound (LIFU), Sham Low-Intensity Focused Ultrasound (LIFU)
ClinicalTrials.gov registration NCT07828483 · first posted Sep 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Assessment of Childbirth-Related Post-Traumatic Stress Disorder
Status at last check: Not yet recruiting · NCT07827508
Childbirth-related Post-traumatic Stress Disorder — City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization
ClinicalTrials.gov registration NCT07827508 · first posted Sep 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
Status at last check: Recruiting · NCT07825857
Methamphetamine Use Disorder — Tirzepatide, Placebo (saline)
ClinicalTrials.gov registration NCT07825857 · first posted Sep 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Imaging Mitochondrial Complex-I in Alcohol Use Disorder
Status at last check: Recruiting · NCT07825818
Alcohol Use Disorder (AUD), Healthy Controls Group - Age and Sex-matched — [F-18]BCPP-EF, [F-18]FDG
ClinicalTrials.gov registration NCT07825818 · first posted Sep 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07824973 · first posted Sep 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting
Status at last check: Not yet recruiting · NCT07824206
Blunted Emotion in Major Depressive Disorder — lumateparone 42 mg once daily, lumateparone
ClinicalTrials.gov registration NCT07824206 · first posted Sep 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism
Status at last check: Recruiting · NCT07824089
Alcohol Use Disorder (AUD), Alcohol Related Liver Disease — Endurance Exercise
ClinicalTrials.gov registration NCT07824089 · first posted Sep 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Longitudinal Effects of Brain Stimulation on Decision-Making and Reward Learning
Status at last check: Not yet recruiting · NCT07823218
Depression / Major Depressive Disorder
ClinicalTrials.gov registration NCT07823218 · first posted Sep 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Biobehavioral Mechanisms of Activity and Loss of Control Eating in Children
Status at last check: Not yet recruiting · NCT07823153
Binge Eating Behaviour, Eating Disorders, Physical Activity, Functional Magnetic Resonance Imaging (fMRI), Ecological Momentary Assessment, Loss of Control Eating — Go/No-go task, Visual food task, Emotion regulation task
ClinicalTrials.gov registration NCT07823153 · first posted Sep 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07822516
Obsessive - Compulsive Disorder
ClinicalTrials.gov registration NCT07822516 · first posted Sep 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07822321 · first posted Sep 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Migration-Focused Adaptation of EMDR for Psychological Distress Among Turkish Migrants
Status at last check: Completed · NCT07822165
Depression, Anxiety, Stress, Social Adaptation — EMDR
ClinicalTrials.gov registration NCT07822165 · first posted Sep 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder
Status at last check: Not yet recruiting · NCT07821840
Generalized Anxiety Disorder — Cannabidiol (CBD) With Cannabinol (CBN) and Cannabigerol (CBG) Oral Tincture (CannaRiver CBD Calm)
ClinicalTrials.gov registration NCT07821840 · first posted Sep 16, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07821060 · first posted Sep 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Building a Computational Model of Auditory Hallucinations
Status at last check: Not yet recruiting · NCT07820553
Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature, Psychosis, SCHIZOPHRENIA 1 (Disorder), Schizophreni-form Disorder
ClinicalTrials.gov registration NCT07820553 · first posted Sep 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial
Status at last check: Not yet recruiting · NCT07820033
Advanced Cancer, Stage IV Solid Tumor Cancer, Stage IV Sarcoma of Bone, Stage IV Lymphoma, Stage IV Melanoma, Endocrine Cancer — Psilocybin (high dose), Psilocybin (low dose), PEARL Therapy
ClinicalTrials.gov registration NCT07820033 · first posted Sep 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07819851 · first posted Sep 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07819773 · first posted Sep 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Preventox - a Digital Intervention for Patients With Intoxications in Intensive Care
Status at last check: Not yet recruiting · NCT07819500
Intoxication, Delirium Tremens (DTs), Poisoning by Psychoactive Substances, Suicidal Attempt — Preventox, a digital self-help tool for patients with intoxications in intensive care., Preventox control group
ClinicalTrials.gov registration NCT07819500 · first posted Sep 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Aerobic Exercise as an Adjunct Therapy for Depression
Status at last check: Recruiting · NCT07819448
Depressive Disorder — Structured Aerobic exercise
ClinicalTrials.gov registration NCT07819448 · first posted Sep 15, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07818889 · first posted Sep 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07818876 · first posted Sep 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Circles of Hope: Group Intervention for Adolescents With Suicidal Symptoms
Status at last check: Not yet recruiting · NCT07818863
Suicidal Ideation — Circles of Hope Group Psychotherapy
ClinicalTrials.gov registration NCT07818863 · first posted Sep 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07818720 · first posted Sep 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Schizophrenia / Schizoaffective Disorder — Transcranial Alternating Current Stimulation (tACS), Sham Transcranial Alternating Current Stimulation (tACS)
ClinicalTrials.gov registration NCT07818668 · first posted Sep 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation
Status at last check: Recruiting · NCT07818564
Phase I — Psilocybin (Usona Institute), Inactive Placebo (Usona Institute)
ClinicalTrials.gov registration NCT07818564 · first posted Sep 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07818161
Traumatic Injury, Posttraumatic Stress Disorder, Depression, Social Determinants of Health — CHW support
ClinicalTrials.gov registration NCT07818161 · first posted Sep 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Validity of the 3-item Patient Health Questionnaire (PHQ-3) for Identifying Moderate-to-Severe Depressive Symptoms Among Elderly Perioperative Patients: A Secondary Analysis of a National Prospective Cohort
Status at last check: Completed · NCT07818057
Depressive Disorder — Retrospective data analysis
ClinicalTrials.gov registration NCT07818057 · first posted Sep 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects
Status at last check: Recruiting · NCT07817069
Treatment Resistant Schizophrenia, Obesity & Overweight, Abdominal Obesity — The Nitraria retusa arm
ClinicalTrials.gov registration NCT07817069 · first posted Sep 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07815691 · first posted Sep 11, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07815210 · first posted Sep 11, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Auricular Vagal Neuromodulation for Depression and Anxiety in Substance Use Disorder
Status at last check: Not yet recruiting · NCT07814755
Substance Use Disorder (SUD) — Transcutaneous Auricular Vagus Nerve Stimulation
ClinicalTrials.gov registration NCT07814755 · first posted Sep 11, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07813962 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Internet-Delivered Acceptance and Commitment Therapy (iACT) for Youth With PTSD and Chronic Pain
Status at last check: Recruiting · NCT07813728
Chronic Pain, PTSD — iACT
ClinicalTrials.gov registration NCT07813728 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effect of an ACT-based Intervention to Reduce Anxiety in Medical Students
Status at last check: Completed · NCT07813520
Anxiety, Somatization, Depressive Symptom, Stress (Psychology) — ACT_based intervention, Active Control group
ClinicalTrials.gov registration NCT07813520 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Activity-Based Intervention to Address Cannabis Use
Status at last check: Not yet recruiting · NCT07813442
Cannabis Use — Motivational and Behavioral Economics Informed Intervention, Enhanced Usual Care
ClinicalTrials.gov registration NCT07813442 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Study on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in Depression
Status at last check: Recruiting · NCT07813169
Major Depression, Anhedonia, Melancholic Depression, Theta Burst Stimulation — Left DLPFC + OFC iTBS, Left DLPFC iTBS
ClinicalTrials.gov registration NCT07813169 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07812987 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Personalising ADHD Medication Treatment for Children and Young People
Status at last check: Not yet recruiting · NCT07812948
ADHD — PETRA decision-aid tool, Best-evidence decision-support tool
ClinicalTrials.gov registration NCT07812948 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Behavioral Activation for Treatment of Depression in Autistic Adolescents With Below Average Intelligence
Status at last check: Recruiting · NCT07812870
Autism, Depressed, Depressed Mood — BA-A
ClinicalTrials.gov registration NCT07812870 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07812714
ADHD
ClinicalTrials.gov registration NCT07812714 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluating the Effects of StrongMinds Community-Based Group Interpersonal Therapy on Depression and Secondary Outcomes in Uganda
Status at last check: Active, not recruiting · NCT07812311
Depression - Major Depressive Disorder — Group Interpersonal Therapy (IPT-G), Enhanced treatment as usual
ClinicalTrials.gov registration NCT07812311 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Expanded-Coming-Out-Proud Group on Reducing Self-stigma for People With a Severe Mental Illness- A Randomized Control Trial With Six-month Follow-up
Status at last check: Completed · NCT07812298
Expanded Coming Out Proud Group, Control Group — Expanded Coming Out Proud group, control group
ClinicalTrials.gov registration NCT07812298 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Transcutaneous Electrical Acupoint Stimulation Combined With Exposure and Response Prevention in the Treatment of Patients With Obsessive-Compulsive Disorder: A Randomized Controlled Trial
Status at last check: Not yet recruiting · NCT07811778
Obsessive Compulsive Disorder (OCD) — Exposure and Response Prevention, Active Transcutaneous Acupoint Electrical Stimulation, Sham Transcutaneous Acupoint Electrical Stimulation
ClinicalTrials.gov registration NCT07811778 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Mobile Application-Based Interventions for Cannabis Use in Young Adults With First Episode Psychosis
Status at last check: Not yet recruiting · NCT07811466
First Episode Psychosis (FEP), Psychosis, Schizophreni-form Disorder, Dependence Addictive — CHAMPS, I Can Change
ClinicalTrials.gov registration NCT07811466 · first posted Sep 10, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07810946 · first posted Sep 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.
Status at last check: Not yet recruiting · NCT07810738
Late Life Treatment Resistant Depression, Depression - Major Depressive Disorder, Treatment Resistant Depression — Aripiprazole Augmentation, Bupropion Augmentation
ClinicalTrials.gov registration NCT07810738 · first posted Sep 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effectiveness of an AI-Integrated Proactive Thought Control Intervention for Young Adults With Social Anxiety Disorder
Status at last check: Completed · NCT07810348
Social Anxiety Disorder (SAD) — AI-Proactive thought control, Cognitive Behavior Therapy, Active Control
ClinicalTrials.gov registration NCT07810348 · first posted Sep 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina
Status at last check: Recruiting · NCT07810322
Opioid Use Disorder, Digital Health Intervention, Telemedicine, Outreach Intervention — emPath Intervention
ClinicalTrials.gov registration NCT07810322 · first posted Sep 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Intramuscular Ketamine for Suicidal Patients in the Evanston Hospital Emergency Department for Suicidal Distress
Status at last check: Enrolling by invitation · NCT07810023
Suicidal, Suicidal Ideation, Suicidal Ideation and Behavior, Depression / Major Depressive Disorder — Ketamine (0.5 mg/kg)
ClinicalTrials.gov registration NCT07810023 · first posted Sep 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07809295 · first posted Sep 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Mental Health Reinforcement in Wayapi and Teko Communities in French Guiana : Evaluation of the Impact of a Mediation Based Activity in Municipalities of Camopi and Trois Saut in French Guiana
Status at last check: Not yet recruiting · NCT07808801
Mental Disease
ClinicalTrials.gov registration NCT07808801 · first posted Sep 9, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07808190 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Comparative Effects of Acceptance and Commitment Therapy, Cognitive Behavioral Therapy, and Treatment-as-Usual on Depression Among People With Marital Crisis
Status at last check: Not yet recruiting · NCT07808021
Depression - Major Depressive Disorder, Anxiety, Marital Conflict — Acceptance and Commitment Therapy, Cognitive Behavioral Therapy
ClinicalTrials.gov registration NCT07808021 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Individual Narratives of Stimulation (ECT and TMS)
Status at last check: Not yet recruiting · NCT07807930
Major Depression — There is no intervention in this observation study (qualitative interviews about past treatment experiences)
ClinicalTrials.gov registration NCT07807930 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
Status at last check: Recruiting · NCT07807865
Generalized Anxiety Disorder — ITI-1284
ClinicalTrials.gov registration NCT07807865 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07807774 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. (MDD)
Status at last check: Not yet recruiting · NCT07807735
Major Depression — Virtual reality
ClinicalTrials.gov registration NCT07807735 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07807462 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07807072 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07806877 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
An Ultra-Brief ICBT Intervention: The 'Things You Do' Program
Status at last check: Recruiting · NCT07806864
Depression, Anxiety — Things You Do Program (Ultra-Brief ICBT), Things You Do Program Plus Personalized Feedback
ClinicalTrials.gov registration NCT07806864 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluation of the Acceptability, Feasibility and Exploration of the Efficacy of an Integrated Care Pathway CARIBOU
Status at last check: Not yet recruiting · NCT07806825
Major Depressive Disorder (MDD) — CARIBOU Integrated Care Pathway, Treatment as Usual (TAU)
ClinicalTrials.gov registration NCT07806825 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder
Status at last check: Not yet recruiting · NCT07806227
Bipolar Disorder Depression — Lurasidone (Latuda)
ClinicalTrials.gov registration NCT07806227 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia
Status at last check: Recruiting · NCT07805980
Schizophrenia, Antipsychotic Induced Weight Gain — Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active, Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Sham
ClinicalTrials.gov registration NCT07805980 · first posted Sep 8, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Dynamic Relationships Between Estrogen Fluctuations, Sleep, and Psychiatric Complexity Among Adolescent Females With ADHD
Status at last check: Not yet recruiting · NCT07805382
ADHD
ClinicalTrials.gov registration NCT07805382 · first posted Sep 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07805200 · first posted Sep 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Uncovering Neurocognitive Mechanisms and Enhancement of Exposure-based Fear Learning With Cognitive Training
Status at last check: Not yet recruiting · NCT07805070
Anxiety, Fear Extinction — Cognitive training, Cognitive training
ClinicalTrials.gov registration NCT07805070 · first posted Sep 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Comparison of Efficacy of Minocyclin and Celecoxib as Adjunctive Treatment in Treatment Resistant Cases of Major Depressive Disorder
Status at last check: Completed · NCT07804979
Major Depressive Disorder (MDD), Treatment-resistant Depression (TRD) — Minocycline, Celecoxib
ClinicalTrials.gov registration NCT07804979 · first posted Sep 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07804459
Depression, Major Depressive Disorder (MDD), Depression - Major Depressive Disorder, Persistent Depressive Disorder, PDD, MDD — Active Repetitive Transcranial Magnetic Stimulation (rTMS), Sham Transcranial Magnetic Stimulation (TMS)
ClinicalTrials.gov registration NCT07804459 · first posted Sep 4, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07803224 · first posted Sep 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07802990
Cannabis Use Disorder — Lemborexant 10mg, Placebo, Brief Behavioural Intervention
ClinicalTrials.gov registration NCT07802990 · first posted Sep 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Discontinuing Psychotropic Medication Before Psychotherapy for PTSD
Status at last check: Not yet recruiting · NCT07802158
Post-traumatic Stress Disorder (PTSD)
ClinicalTrials.gov registration NCT07802158 · first posted Sep 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Prospective, Observational, Single-Arm, Multicenter Real-World Study Evaluating the Treatment Pattern, Safety and Effectiveness of Xanomeline and Trospium Chloride Capsules (KarXT) in the Treatment of Chinese Adult Participants With Schizophrenia
Status at last check: Not yet recruiting · NCT07802132
Schizophrenia Disorder — Xanomeline and trospium chloride (KarXT)
ClinicalTrials.gov registration NCT07802132 · first posted Sep 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07801703 · first posted Sep 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Comparative Efficacy of Cognitive Behavioral and Mindfulness Therapies in Reducing Post-Traumatic Stress Disorder Among Interpersonal Violence Survivors
Status at last check: Active, not recruiting · NCT07801534
ClinicalTrials.gov registration NCT07801534 · first posted Sep 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07801079 · first posted Sep 3, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07800663 · first posted Sep 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder
Status at last check: Recruiting · NCT07800520
Opioid Use Disorder, OAT — [11C]OMAR
ClinicalTrials.gov registration NCT07800520 · first posted Sep 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07800299 · first posted Sep 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Investigation of the Association of Multimodal Neuroimaging and Peripheral Biomarkers With Executive Functions and Emotional Regulation in Adolescents With Attention-Deficit/Hyperactivity Disorder
Status at last check: Active, not recruiting · NCT07800117
Attention-Deficit/Hyperactivity Disorder (ADHD) — No Intervention
ClinicalTrials.gov registration NCT07800117 · first posted Sep 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Caplyta Versus Placebo for Adults With Social Anxiety Disorder
Status at last check: Recruiting · NCT07799493
Social Anxiety Disorder (SAD) — Lumateperone 42 mg, Placebo
ClinicalTrials.gov registration NCT07799493 · first posted Sep 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07799480 · first posted Sep 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07798986 · first posted Sep 2, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Frequency- and Intensity-Dependent After-Effects of High-Definition Transcranial Alternating Current Stimulation on Resting-State Electroencephalography
Status at last check: Completed · NCT07798804
Schizophrenia With Auditory Hallucinations — high-definition transcranial alternating current stimulation(HD-tACS), sham high-definition transcranial alternating current stimulation(HD-tACS)
ClinicalTrials.gov registration NCT07798804 · first posted Sep 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07798063 · first posted Sep 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Trauma Informed Goal Management Training With a "Support Person" Module for Individuals Impacted by Post-Traumatic Stress
Status at last check: Not yet recruiting · NCT07797543
Post Traumatic Stress — Trauma-Informed Goal Management Training (TIGMT), Trauma Informed Goal Management Training - Assist (TIGMT-Assist)
ClinicalTrials.gov registration NCT07797543 · first posted Sep 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07796568 · first posted Sep 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Prescribing the Right Agent for Depression in Adults
Status at last check: Not yet recruiting · NCT07796295
Major Depressive Disorder (MDD) — PRADA Tool, PETRUSHKA Tool
ClinicalTrials.gov registration NCT07796295 · first posted Sep 1, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The ConCERN Intervention for Loved Ones of Those With Opioid Use Disorder
Status at last check: Not yet recruiting · NCT07795840
Opioid Use Disorder — ConCERN intervention, Treatment as Usual
ClinicalTrials.gov registration NCT07795840 · first posted Aug 31, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
Status at last check: Recruiting · NCT07795554
Schizophrenia Spectrum, Schizophrenia, Antipsychotic Induced Weight Gain — dTMS of accelerated intermittent theta burst stimulation, ACC-iTBS, Sham stimulation
ClinicalTrials.gov registration NCT07795554 · first posted Aug 31, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Young Athlete Body Project (YABP) - Prevention of Body Dissatisfaction and Eating Disorders Among Adolescent Athletes
Status at last check: Enrolling by invitation · NCT07795333
Eating Disorders in Adolescence, Body Dissatisfaction, Mental Health — Young Athlete Body Project
ClinicalTrials.gov registration NCT07795333 · first posted Aug 31, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07794332 · first posted Aug 31, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Postpartum Depressive Symptoms, Breastfeeding — Mediterranean diet, Standard nutrition information
ClinicalTrials.gov registration NCT07793864 · first posted Aug 31, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3
Status at last check: Recruiting · NCT07793383
Opioid Abuse (Disorder), Clinical Decision Support — Refined EMBED CDS, Provider alert that nurse completed COWS
ClinicalTrials.gov registration NCT07793383 · first posted Aug 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07793071 · first posted Aug 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder
Status at last check: Recruiting · NCT07793045
Attention-Deficit/Hyperactivity Disorder (ADHD) — Music-Based Binaural Beats Stimulation, Music Listening Without Binaural Beats
ClinicalTrials.gov registration NCT07793045 · first posted Aug 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07792538 · first posted Aug 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07792252 · first posted Aug 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07792122 · first posted Aug 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07791901 · first posted Aug 28, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases
Status at last check: Not yet recruiting · NCT07791212
Neuropsychiatric Symptom
ClinicalTrials.gov registration NCT07791212 · first posted Aug 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Parental Stress and Its Relationship With Perceived Social Support and Screen Time Among Caregivers of Children With Attention-Deficit/Hyperactivity Disorder
Status at last check: Not yet recruiting · NCT07790432
ADHD - Attention Deficit Disorder With Hyperactivity
ClinicalTrials.gov registration NCT07790432 · first posted Aug 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Activating Voice Journaling for Mental Health With Voice Biomarkers
Status at last check: Completed · NCT07789808
Depression / Major Depressive Disorder, Anxiety
ClinicalTrials.gov registration NCT07789808 · first posted Aug 27, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia
Status at last check: Not yet recruiting · NCT07788755
Schizophrenia, Schizoaffective Disorder, Cognitive Impairment, Visual Impairment — Perceptual Discrimination Training, Cognitive Control Training
ClinicalTrials.gov registration NCT07788755 · first posted Aug 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Alcohol Use Disorder (AUD) — Alcohol Cue Reactivity Paradigm
ClinicalTrials.gov registration NCT07788716 · first posted Aug 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Applying Neuromodulation to Boost the Efficacy of Motivational Interviewing
Status at last check: Not yet recruiting · NCT07787572
Cannabis Use Disorder — transcranial alternating current stimulation, sham transcranial alternating current stimulation, Motivational interviewing (MI)
ClinicalTrials.gov registration NCT07787572 · first posted Aug 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase
Status at last check: Recruiting · NCT07787039
Opioid Use Disorder — STORC
ClinicalTrials.gov registration NCT07787039 · first posted Aug 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis
Status at last check: Recruiting · NCT07786714
Clinical High Risk for Psychosis (CHR), Psychotic Disorders, Prodromal Symptoms — Active Intermittent Theta Burst Stimulation (BEAM-F3 Targeting), Sham Comparator: Sham iTBS
ClinicalTrials.gov registration NCT07786714 · first posted Aug 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder
Status at last check: Recruiting · NCT07786454
Generalized Anxiety Disorder — SEP-363856
ClinicalTrials.gov registration NCT07786454 · first posted Aug 26, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Adjunctive Probiotic Therapy in Major Depressive Disorder (ProMOOD)
Status at last check: Not yet recruiting · NCT07786285
Depression / Major Depressive Disorder — OMNi-BiOTiC® STRESS Repair, Matched Placebo Powder for Oral Solution
ClinicalTrials.gov registration NCT07786285 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Individualized (fMRI-guided) TMS Intervention for Post-Traumatic Stress Disorder (PTSD)
Status at last check: Not yet recruiting · NCT07785908
PTSD, Post Traumatic Stress Disorder (PTSD) — Active Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS)
ClinicalTrials.gov registration NCT07785908 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Multicenter Real-World Study Evaluating the Efficacy and Safety of Shugan Jieyu Capsules in the Treatment of Depression
Status at last check: Not yet recruiting · NCT07785284
Outpatients or Inpatients With Depression — Shugan Jieyu Capsules
ClinicalTrials.gov registration NCT07785284 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07785167 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101
Status at last check: Recruiting · NCT07785102
Major Depression — TMS, NRX-101
ClinicalTrials.gov registration NCT07785102 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Immersive Gamified Virtual Reality-Based Training for Children With Attention Deficit Hyperactivity Disorder
Status at last check: Not yet recruiting · NCT07784933
ADHD, Social Skills — Immersive gamified virtual reality-based training (iGameVRT), Traditional social skills training
ClinicalTrials.gov registration NCT07784933 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
THRIVE: A Recovery-Focused Suicide Prevention Intervention in Crisis Stabilization Centers
Status at last check: Not yet recruiting · NCT07784634
Suicide — Toward Hope, Recovery, Interpersonal Growth, Values, and Engagement (THRIVE), Center Care as Usual
ClinicalTrials.gov registration NCT07784634 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD
Status at last check: Recruiting · NCT07784348
ADHD — Central executive training, Behavioral parent training
ClinicalTrials.gov registration NCT07784348 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07784244 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Precision Closed-loop Brain-Computer Interface Neuromodulation for Treatment-Resistant Depression
Status at last check: Not yet recruiting · NCT07783906
Treatment-Resistant Major Depressive Disorder, Major Depressive Disorder — Closed-loop Deep Brain Stimulation (DBS), Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
ClinicalTrials.gov registration NCT07783906 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07783633 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Varenicline as a Treatment for Cannabis Use Disorder
Status at last check: Not yet recruiting · NCT07783555
Cannabis Abuse — Varenicline (Chantix), Placebo
ClinicalTrials.gov registration NCT07783555 · first posted Aug 25, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Grappling With Trauma: Brazilian Jiu-Jitsu for First Responders
Status at last check: Recruiting · NCT07783516
Post-traumatic Stress Disorder (PTSD), Trauma and Stress Related Disorders, Occupational Stress, Emotional Regulation Difficulties, Anger Problems, Relational Problems, Irritability — Brazilian Jiu-Jitsu Program
ClinicalTrials.gov registration NCT07783516 · first posted Aug 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07783490
Suicide Prevention, Suicide Safety Planning, Suicidal Ideation, Suicide Attempt — Local Care Continuity, Centralized Care Navigation
ClinicalTrials.gov registration NCT07783490 · first posted Aug 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07783373 · first posted Aug 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Written Exposure in Substance Treatment (WEST 3.0): Randomized Controlled Trial
Status at last check: Not yet recruiting · NCT07782268
Posttraumatic Stress Disorder (PTSD), Substance Use Disorder (SUD) — Written Exposure Therapy, Treatment as Usual
ClinicalTrials.gov registration NCT07782268 · first posted Aug 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Psychoeducation-Supported Breathing and Relaxation for Earthquake Survivors
Status at last check: Completed · NCT07781904
Post-Traumatic Stress Symptoms, Poor Sleep Quality — Psychoeducation-Supported Breathing and Relaxation Program
ClinicalTrials.gov registration NCT07781904 · first posted Aug 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07781748 · first posted Aug 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant Monotherapy
Status at last check: Not yet recruiting · NCT07781293
Major Depressive Disorder (MDD), Major Depressive Disorder With Psychotic Features — Lurasidone, Placebo, Background Antidepressant Therapy
ClinicalTrials.gov registration NCT07781293 · first posted Aug 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Supported Online Self-Help for Veterans With Depression in Primary Care
Status at last check: Not yet recruiting · NCT07781228
Depression — Enhanced Usual Care (EUC), Supported Online Self-help for Depression (SOS-Depression)
ClinicalTrials.gov registration NCT07781228 · first posted Aug 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia
Status at last check: Not yet recruiting · NCT07781007
Schizophrenia — Scaffolding-Based Board Game Intervention
ClinicalTrials.gov registration NCT07781007 · first posted Aug 24, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07780695 · first posted Aug 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization
Status at last check: Enrolling by invitation · NCT07780097
Opioid Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe — TRTME
ClinicalTrials.gov registration NCT07780097 · first posted Aug 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Stratified Care Intervention for Suicidal Ideation, Depression, and Non-Suicidal Self-Injury in Adolescents (Reframe-IT+ & CARIBOU)
Status at last check: Active, not recruiting · NCT07780084
Depression in Adolescence, Suicidal Ideation, Non Suicidal Self Injury — Reframe-IT and CARIBOU
ClinicalTrials.gov registration NCT07780084 · first posted Aug 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Medically Tailored Groceries and Mental Health Study
Status at last check: Recruiting · NCT07779707
Depression / Major Depressive Disorder, Food Insecurity — Medically Tailored, Home-delivered Groceries, Active Comparison Group: Monthly Grocery Gift Card
ClinicalTrials.gov registration NCT07779707 · first posted Aug 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07779330 · first posted Aug 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07779226 · first posted Aug 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Utility of a Mindfulness App for Outpatients Awaiting Appointments for Mental Health Interventions
Status at last check: Active, not recruiting · NCT07778680
Depression Anxiety Disorder, Anxiety and Depression — Mobile App - AmDTx (New name DawnDTx), Placebo App
ClinicalTrials.gov registration NCT07778680 · first posted Aug 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Opioid Use Disorder, mHealth, Peer Support — Vira Platform, Treatment-As-Usual
ClinicalTrials.gov registration NCT07778394 · first posted Aug 21, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07777380 · first posted Aug 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07777328 · first posted Aug 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Group Dialectical Behaviour Therapy (DBT) Skills Training for First Episode Psychosis
Status at last check: Not yet recruiting · NCT07777315
Psychosis — group DBT
ClinicalTrials.gov registration NCT07777315 · first posted Aug 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07776769 · first posted Aug 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Substance Use in Pregnancy - Optimizing Retention in Treatment by Maximizing Opportunities for Management
Status at last check: Not yet recruiting · NCT07776457
Pregnancy, Substance Use Disorder (SUD) — Contingency Management, Social Drivers of Health Screening
ClinicalTrials.gov registration NCT07776457 · first posted Aug 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Remote Group Cognitive Behavioral Skills Training for Mexican University Students With Anxiety or Depression
Status at last check: Not yet recruiting · NCT07776236
Depression and Anxiety Symptoms — Remote group cognitive behavioral skills training, Mood monitoring web application
ClinicalTrials.gov registration NCT07776236 · first posted Aug 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Closed-loop TBS Targeting rPO for the Core Clinical Features of Methamphetamine Use Disorder
Status at last check: Active, not recruiting · NCT07775807
Methamphetamine Use Disorder, Substance Use Disorder, Cue-reactivity, Craving — Closed-loop Theta-Burst Stimulation (TBS) Targeting rPO
ClinicalTrials.gov registration NCT07775807 · first posted Aug 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Home-Based Wearable rTMS Therapy for Moderate to Severe Depression
Status at last check: Not yet recruiting · NCT07775586
Major Depressive Disorder — rTMS-Tiny Treatment, Sham Stimulation
ClinicalTrials.gov registration NCT07775586 · first posted Aug 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Status at last check: Recruiting · NCT07775300
Depressive Disorder, Major — Brenipatide, Placebo
ClinicalTrials.gov registration NCT07775300 · first posted Aug 20, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Status at last check: Not yet recruiting · NCT07774702
Methamphetamine Use Disorder — Psilocybin (single oral capsule administered at one of two dose levels, Dose A or Dose B; specific doses withheld during conduct)., Manualized cognitive behavioral therapy platform (2 preparation + 2 integration sessions).
ClinicalTrials.gov registration NCT07774702 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Treatment With Repetitive Transcranial Magnetic Stimulation in Peripartal Depression
Status at last check: Recruiting · NCT07774559
Depression During Pregnancy, Postpartum Depression (PPD), Peripartum Depression — Repetitive transcranial magnetic stimulation, Sham repetitive transcranial magnetic stimulation
ClinicalTrials.gov registration NCT07774559 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Anxiety, Anxiety Acute, Anxiety Chronic, Anxiety and Mood Disorders, Social Anxiety Disorder, Panic Disorder (With or Without Agoraphobia), Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Specific Phobia — Cognitive therapy, Behavioral therapy, Mindfulness-based…
ClinicalTrials.gov registration NCT07774481 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07773935 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
Status at last check: Enrolling by invitation · NCT07773883
ADHD — Solriamfetol
ClinicalTrials.gov registration NCT07773883 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07773831 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Imaging Mitochondrial Complex-I in Cocaine Use Disorder: a [F-18]BCPP-EF PET Study
Status at last check: Recruiting · NCT07773649
Cocaine Use Disorder, Healthy Controls Group - Age and Sex-matched — [F-18]BCPP-EF
ClinicalTrials.gov registration NCT07773649 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
CODEPAD-III (Collaborative Outcomes of DEpression and Pain Associated With Delivery-III)
Status at last check: Not yet recruiting · NCT07773259
Depression, Postpartum, Pain, Mental Health — Collaborative Psychological Model (CPM), Intervention common to both arms, Telephone-based support (Control)
ClinicalTrials.gov registration NCT07773259 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Status at last check: Recruiting · NCT07772960
Alcohol Use Disorder (AUD), Obesity (BMI Equal to or >30) — Placebo, Semaglutide 1.0 mg, Semaglutide 2.0 mg
ClinicalTrials.gov registration NCT07772960 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07772531
Major Depressive Disorder — BMS-986511, Placebo
ClinicalTrials.gov registration NCT07772531 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder
Status at last check: Recruiting · NCT07772401
Social Anxiety Disorder, Social Fear — taVNS, sham-taVNS
ClinicalTrials.gov registration NCT07772401 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)
Status at last check: Not yet recruiting · NCT07772349
Schizophrenia — Active rTMS, Strong Cognitive Training, Sham rTMS
ClinicalTrials.gov registration NCT07772349 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Short-Term Psychodynamic Group Therapy for Problematic Pornography Use
Status at last check: Completed · NCT07772193
Addiction — Short-Term Psychodynamic Group Therapy
ClinicalTrials.gov registration NCT07772193 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Evaluation of a Modularized Cognitive Behavioral Group Therapy Programme for Young Adults (CHANGE-Study)
Status at last check: Not yet recruiting · NCT07772180
Psychiatric Disorder — CHANGE - modularized group psychotherapy
ClinicalTrials.gov registration NCT07772180 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Identifying Multidimensional Signatures of Gastric Interoception in Functional Dyspepsia
Status at last check: Recruiting · NCT07772167
Functional Dyspepsia, Anorexia Nervosa — Functional magnetic resonance imaging (fMRI)
ClinicalTrials.gov registration NCT07772167 · first posted Aug 19, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07771530 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders, Major Depressive Disorder is Suspected to Have the Greatest Burden by 2030,Kynurenine Pathway is Major Route Through Which the Essential Amino Acid Tryptophan is Metabolised and Activated in Time of Stress and Immune Activation.
Status at last check: Not yet recruiting · NCT07771517
Major Depressive Disorder (MDD)
ClinicalTrials.gov registration NCT07771517 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07771426 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effect of a Telehealth Intervention on Depressive Symptoms Among Caregivers of Patients With Cerebral Palsy Receiving Home Care
Status at last check: Completed · NCT07771413
Depression — Behavioral Treatment
ClinicalTrials.gov registration NCT07771413 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Mental Health, Cultural Adaptation, Psychotherapy, Mood Disorders, Culturally Responsive Care, Asian, Digital Health Intervention — Culturally-attuned digital tools
ClinicalTrials.gov registration NCT07771322 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Continuous Theta Burst Stimulation for Generalized Anxiety Disorder
Status at last check: Recruiting · NCT07770919
Generalized Anxiety Disorder — Continuous Theta Burst Stimulation of the Right Posterior Parietal Cortex, Continuous Theta Burst Stimulation of the Right Dorsolateral Prefrontal Cortex
ClinicalTrials.gov registration NCT07770919 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use Disorder
Status at last check: Not yet recruiting · NCT07770555
Opioid Use Disorder, Tobacco Use Disorder — Deep TMS System With H4 Coil
ClinicalTrials.gov registration NCT07770555 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Status at last check: Not yet recruiting · NCT07770282
Schizophrenia Disorder, Metabolic Syndrome, Antipsychotic-induced Weight Gain, Cardiovascular Risk, Insulin Resistance — Semaglutide + TAU, Placebo + TAU
ClinicalTrials.gov registration NCT07770282 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Imagery Rescripting for Traumatic Panic Attack Memories
Status at last check: Completed · NCT07769996
Panic Disorder — Imagery Rescripting
ClinicalTrials.gov registration NCT07769996 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care
Status at last check: Not yet recruiting · NCT07769749
SCHIZOPHRENIA 1 (Disorder) — physiotherapy, 2 x a week for 6 weeks, basal therapy, 2 x a week for 6 weeks, Standard therapy group
ClinicalTrials.gov registration NCT07769749 · first posted Aug 18, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Effect of a Psychiatric Nursing Approach Based on the Tidal Model on Psychological Resilience and Self-Compassion Levels in Patients Diagnosed With Anxiety Disorder
Status at last check: Completed · NCT07768995
Anxiety Disorders, Psychiatric Nursing, Nursing Models, Psychological Resilience, Self-Compassion, Telehealth, Patient-Centered Care, Mental Health Recovery — Online Psychiatric Nursing Approach Based on the Tidal Model
ClinicalTrials.gov registration NCT07768995 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Electrophysiologic Mechanisms of Ketamine Antidepressant Response
Status at last check: Not yet recruiting · NCT07768618
Epilepsy, Depressive Symptoms — Ketamine
ClinicalTrials.gov registration NCT07768618 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effectiveness of Cognitive Behavioral Intervention for Trauma in Schools (CBITS): A Study With Pakistani Adolescents
Status at last check: Recruiting · NCT07768540
Post Traumatic Stress Symptoms, Psychological Distress, Trauma Exposure — cognitive behavioral intervention for trauma in schools
ClinicalTrials.gov registration NCT07768540 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Accelerated Versus Standard Intermittent Theta Burst Stimulation for Major Depressive Disorder
Status at last check: Recruiting · NCT07768397
Major Depressive Disorder — Accelerated Intermittent Theta Burst Stimulation, Standard Intermittent Theta Burst Stimulation
ClinicalTrials.gov registration NCT07768397 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Effectiveness of Online Group Dialectical Behavioral Therapy on Bulimia Nervosa
Status at last check: Completed · NCT07768319
Bulimia Nervosa — Online Group Dialectical Behavioral Therapy, Face-to-face Group Dialectical Behavioral Therapy
ClinicalTrials.gov registration NCT07768319 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Leuven Longitudinal Late-Life Depression Study
Status at last check: Enrolling by invitation · NCT07768098
Late Life Depression (LLD)
ClinicalTrials.gov registration NCT07768098 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Substance Use Disorder (SUD) — real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback
ClinicalTrials.gov registration NCT07768007 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07767903 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Efficacy of Cognitive Behavioural Therapy for Insomnia and Bright Light Therapy in Adolescents With ADHD, Insomnia, and Evening Chronotype
Status at last check: Not yet recruiting · NCT07767617
Insomnia, ADHD, Eveningness, Chronotype, Treatment Effectiveness — CBT-I with Bright Light Group, CBT-I with Placebo Light Group
ClinicalTrials.gov registration NCT07767617 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Effectiveness of the MindBridge Mobile Health Module for Young Adults at Risk of Suicide
Status at last check: Not yet recruiting · NCT07767604
Suicidal Ideation — MindBridge Mobile Health Intervention, Attention-Matched General Well-Being Program
ClinicalTrials.gov registration NCT07767604 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
Status at last check: Not yet recruiting · NCT07767526
Schizophrenia, Antipsychotic Drug — Xingqi Daozhi Decoction, Placebo Group
ClinicalTrials.gov registration NCT07767526 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Eye Movement Intervention With Different Memory Reactivation Procedures for Intrusive Traumatic Memories
Status at last check: Recruiting · NCT07767396
Post-traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s) — Unconscious Trauma Reactivation plus Eye Movements, Active Trauma Memory Reactivation plus Eye Movements, Neutral Memory Reactivation plus Eye Movements
ClinicalTrials.gov registration NCT07767396 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07767032 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07766798 · first posted Aug 17, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07766291 · first posted Aug 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
NEST: A Group Intervention for Parents With Complex PTSD
Status at last check: Recruiting · NCT07766265
Complex Post-Traumatic Stress Disorder — Trauma-Informed Parenting Group Intervention
ClinicalTrials.gov registration NCT07766265 · first posted Aug 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression
Status at last check: Recruiting · NCT07766161
Postpartum Depression (PPD) — Light therapy
ClinicalTrials.gov registration NCT07766161 · first posted Aug 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07765693 · first posted Aug 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07764536 · first posted Aug 14, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Multimodal Cohort Study of Generalized Anxiety Disorder
Status at last check: Not yet recruiting · NCT07764211
Generalized Anxiety Disorder (GAD)
ClinicalTrials.gov registration NCT07764211 · first posted Aug 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on Inhibitory Control in Obsessive-Compulsive Disorder
Status at last check: Enrolling by invitation · NCT07763977
Obsessive Compulsive Disorder (OCD) — Calcitriol and Iron Supplements
ClinicalTrials.gov registration NCT07763977 · first posted Aug 13, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Study of rTMS in Maintenance in Treatment Resistant Depression
Status at last check: Not yet recruiting · NCT07760168
Treatment Resistant Depression (TRD) — Transcranial Magnetic Stimulation, quetiapine
ClinicalTrials.gov registration NCT07760168 · first posted Aug 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia
Status at last check: Recruiting · NCT07759895
Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder, Schizophrenia and Predominant Negative Symptoms — Deferiprone (DFP), N-Acetyl Cysteine (NAC)
ClinicalTrials.gov registration NCT07759895 · first posted Aug 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care SettinGs in Arkansas (STRONG Moms)
Status at last check: Recruiting · NCT07759882
Written Exposure Therapy — Written Exposure Therapy (WET)
ClinicalTrials.gov registration NCT07759882 · first posted Aug 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
Status at last check: Not yet recruiting · NCT07759869
SCHIZOPHRENIA 1 (Disorder) — HS-10380
ClinicalTrials.gov registration NCT07759869 · first posted Aug 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07759154 · first posted Aug 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.
ClinicalTrials.gov registration NCT07759128 · first posted Aug 12, 2026
Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.
A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.